{"parse":{"title":"Pharmacogenetics","pageid":1889064,"revid":853842368,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"plainlinks metadata ambox ambox-content ambox-multiple_issues compact-ambox\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/40px-Ambox_important.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/60px-Ambox_important.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Ambox_important.svg/80px-Ambox_important.svg.png 2x\" data-file-width=\"40\" data-file-height=\"40\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\"><div class=\"mw-collapsible\" style=\"width:95%; margin: 0.2em 0;\"><b>This article has multiple issues.</b> Please help <b><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacogenetics&amp;action=edit\">improve it</a></b> or discuss these issues on the <b><a href=\"/wiki/Talk:Pharmacogenetics\" title=\"Talk:Pharmacogenetics\">talk page</a></b>. <small><i>(<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove these template messages</a>)</i></small>\n<div class=\"mw-collapsible-content\" style=\"margin-top: 0.3em;\">\n      <table class=\"plainlinks metadata ambox ambox-style ambox-Cleanup\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/40px-Edit-clear.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/60px-Edit-clear.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/f/f2/Edit-clear.svg/80px-Edit-clear.svg.png 2x\" data-file-width=\"48\" data-file-height=\"48\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article may <b>require <a href=\"/wiki/Wikipedia:Cleanup\" title=\"Wikipedia:Cleanup\">cleanup</a></b> to meet Wikipedia's <a href=\"/wiki/Wikipedia:Manual_of_Style\" title=\"Wikipedia:Manual of Style\">quality standards</a>. The specific problem is: <b>Incoherent presentation</b><span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacogenetics&amp;action=edit\">improve this article</a> if you can.</span>  <small><i>(February 2016)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Refimprove\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Question_book-new.svg\" class=\"image\"><img alt=\"\" src=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png\" width=\"50\" height=\"39\" srcset=\"//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x\" data-file-width=\"512\" data-file-height=\"399\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article <b>needs additional citations for <a href=\"/wiki/Wikipedia:Verifiability\" title=\"Wikipedia:Verifiability\">verification</a></b>.<span class=\"hide-when-compact\"> Please help <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Pharmacogenetics&amp;action=edit\">improve this article</a> by <a href=\"/wiki/Help:Introduction_to_referencing_with_Wiki_Markup/1\" title=\"Help:Introduction to referencing with Wiki Markup/1\">adding citations to reliable sources</a>. Unsourced material may be challenged and removed.</span>  <small><i>(February 2016)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-unreliable_sources\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><a href=\"/wiki/File:Text_document_with_red_question_mark.svg\" class=\"image\"><img alt=\"Text document with red question mark.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Text_document_with_red_question_mark.svg/40px-Text_document_with_red_question_mark.svg.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Text_document_with_red_question_mark.svg/60px-Text_document_with_red_question_mark.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Text_document_with_red_question_mark.svg/80px-Text_document_with_red_question_mark.svg.png 2x\" data-file-width=\"48\" data-file-height=\"48\" /></a></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">Some of this article's <a href=\"/wiki/Wikipedia:Citing_sources\" title=\"Wikipedia:Citing sources\">listed sources</a> <b>may not be <a href=\"/wiki/Wikipedia:Identifying_reliable_sources\" title=\"Wikipedia:Identifying reliable sources\">reliable</a></b>.<span class=\"hide-when-compact\"> Please help this article by looking for better, more reliable sources. Unreliable citations may be challenged or deleted.</span>  <small><i>(February 2016)</i></small><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<table class=\"plainlinks metadata ambox ambox-content ambox-Update\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><div style=\"width:52px\"><img alt=\"Ambox current red.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/98/Ambox_current_red.svg/42px-Ambox_current_red.svg.png\" width=\"42\" height=\"34\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/9/98/Ambox_current_red.svg/63px-Ambox_current_red.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/98/Ambox_current_red.svg/84px-Ambox_current_red.svg.png 2x\" data-file-width=\"360\" data-file-height=\"290\" /></div></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This article needs to be <b>updated</b>.<span class=\"hide-when-compact\"> Please update this article to reflect recent events or newly available information.</span>  <small><i>(February 2016)</i></small></div></td></tr></tbody></table>\n    </div>\n</div><small class=\"hide-when-compact\"><i> (<a href=\"/wiki/Help:Maintenance_template_removal\" title=\"Help:Maintenance template removal\">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table>\n<p><b>Pharmacogenetics</b> is the study of inherited <a href=\"/wiki/Genetics\" title=\"Genetics\">genetic</a> differences in drug <a href=\"/wiki/Metabolic_pathway\" title=\"Metabolic pathway\">metabolic pathways</a> (and other pharmacological principles, like enzymes, messengers and receptors) which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects.<sup id=\"cite_ref-Klotz-2007_1-0\" class=\"reference\"><a href=\"#cite_note-Klotz-2007-1\">&#91;1&#93;</a></sup> The term <i>pharmacogenetics</i> is often used interchangeably with the term <i><a href=\"/wiki/Pharmacogenomics\" title=\"Pharmacogenomics\">pharmacogenomics</a></i> which also investigates the role of acquired and inherited genetic differences in relation to drug response and drug behaviour through a systematic examination of genes, gene products, and inter- and intra-individual variation in gene expression and function.<sup id=\"cite_ref-2\" class=\"reference\"><a href=\"#cite_note-2\">&#91;2&#93;</a></sup>\n</p><p>In oncology, <i>pharmacogenetics</i> historically is the study of <a href=\"/wiki/Germline_mutation\" title=\"Germline mutation\">germline mutations</a> (e.g., <a href=\"/wiki/Single-nucleotide_polymorphism\" title=\"Single-nucleotide polymorphism\">single-nucleotide polymorphisms</a> affecting genes coding for liver enzymes responsible for drug deposition and <a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">pharmacokinetics</a>), whereas <i>pharmacogenomics</i> refers to <a href=\"/wiki/Mutation\" title=\"Mutation\">somatic mutations</a> in <a href=\"/wiki/Cancer\" title=\"Cancer\">tumoral</a> DNA leading to alteration in drug response (e.g., <a href=\"/wiki/KRAS\" title=\"KRAS\">KRAS</a> mutations in patients treated with <a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">anti-Her1</a> <a href=\"/wiki/Biologic_medical_product\" class=\"mw-redirect\" title=\"Biologic medical product\">biologics</a>).<sup id=\"cite_ref-pmid10866212_3-0\" class=\"reference\"><a href=\"#cite_note-pmid10866212-3\">&#91;3&#93;</a></sup> Pharmacogenetics is believed to account for inter-ethnic differences (e.g., between patients of Asian, Caucasian and African descent) in adverse events and efficacy profiles of many widely used drugs in cancer chemotherapy.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Predicting_drug-drug_interactions\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Predicting drug-drug interactions</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#History\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Thiopurines_and_TPMT_(thiopurine_methyl_transferase)\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Thiopurines and TPMT (thiopurine methyl transferase)</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#Hepatitis_C\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Hepatitis C</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Integrating_into_the_health_care_system\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">Integrating into the health care system</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Technological_advances\"><span class=\"tocnumber\">5.1</span> <span class=\"toctext\">Technological advances</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-7\"><a href=\"#Ethics\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">Ethics</span></a></li>\n<li class=\"toclevel-1 tocsection-8\"><a href=\"#See_also\"><span class=\"tocnumber\">7</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-9\"><a href=\"#References\"><span class=\"tocnumber\">8</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-10\"><a href=\"#Further_reading\"><span class=\"tocnumber\">9</span> <span class=\"toctext\">Further reading</span></a></li>\n<li class=\"toclevel-1 tocsection-11\"><a href=\"#External_links\"><span class=\"tocnumber\">10</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Predicting_drug-drug_interactions\">Predicting drug-drug interactions</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=1\" title=\"Edit section: Predicting drug-drug interactions\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Much of current clinical interest is at the level of pharmacogenetics, involving variation in genes involved in <a href=\"/wiki/Drug_metabolism\" title=\"Drug metabolism\">drug metabolism</a> with a particular emphasis on improving drug safety. The wider use of pharmacogenetic testing is viewed by many as an outstanding opportunity to improve prescribing safety and efficacy. Driving this trend are the 106,000 deaths and 2.2 Million serious events caused by adverse drug reactions in the US each year.<sup id=\"cite_ref-pmid9555760_5-0\" class=\"reference\"><a href=\"#cite_note-pmid9555760-5\">&#91;5&#93;</a></sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Identifying_reliable_sources_(medicine)\" title=\"Wikipedia:Identifying reliable sources (medicine)\"><span title=\"Material near this tag may rely on an unreliable or less reliable medical source. (February 2016)\">unreliable medical source?</span></a></i>&#93;</sup> As such ADRs are responsible for 5-7% of hospital admissions in the US and Europe, lead to the withdrawal of 4% of new medicines, and cost society an amount equal to the costs of drug treatment.<sup id=\"cite_ref-Ingelman-Sundberg_2005_6-0\" class=\"reference\"><a href=\"#cite_note-Ingelman-Sundberg_2005-6\">&#91;6&#93;</a></sup>\n</p><p>Comparisons of the list of drugs most commonly implicated in adverse drug reactions with the list of metabolizing enzymes with known <a href=\"/wiki/Polymorphism_(biology)\" title=\"Polymorphism (biology)\">polymorphisms</a> found that drugs commonly involved in adverse drug reactions were also those that were metabolized by enzymes with known polymorphisms (see Phillips, 2001).\n</p><p>Scientists and doctors are using this new technology for a variety of things, one being improving the efficacy of drugs. In psychology, we can predict quite accurately which anti-depressant a patient will best respond to by simply looking into their genetic code.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"This claim needs references to reliable sources. (September 2013)\">citation needed</span></a></i>&#93;</sup><sup class=\"noprint Inline-Template\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Accuracy_dispute#Disputed_statement\" title=\"Wikipedia:Accuracy dispute\"><span title=\"The material near this tag is possibly inaccurate or nonfactual. (February 2016)\">dubious</span></a>&#32;<span class=\"metadata\"> &#8211; <a href=\"/wiki/Talk:Pharmacogenetics#Dubious\" title=\"Talk:Pharmacogenetics\">discuss</a></span></i>&#93;</sup> This is a huge step from the previous practice of adjusting and experimenting with different medications to get the best response. Antidepressants also have a large percentage of unresponsive patients and poor prediction rate of ADRs (<a href=\"/wiki/Adverse_drug_reactions\" class=\"mw-redirect\" title=\"Adverse drug reactions\">adverse drug reactions</a>). In depressed patients, 30% are not helped by <a href=\"/wiki/Antidepressant\" title=\"Antidepressant\">antidepressants</a>. In psychopharmacological therapy, a patient must be on a drug for 2 weeks before the effects can be fully examined and evaluated. For a patient in that 30%, this could mean months of trying medications to find an antidote to their pain. Any assistance in predicting a patient\u2019s drug reaction to psychopharmacological therapy should be taken advantage of. Pharmacogenetics is a very useful and important tool in predicting which drugs will be effective in various patients.<sup id=\"cite_ref-pmid20205659_7-0\" class=\"reference\"><a href=\"#cite_note-pmid20205659-7\">&#91;7&#93;</a></sup> The drug Plavix blocks platelet reception and is the second best selling prescription drug in the world, however, it is known to warrant different responses among patients.<sup id=\"cite_ref-urlThe_10_Biggest-Selling_Drugs_That_Are_About_to_Lose_Their_Patent_-_DailyFinance_8-0\" class=\"reference\"><a href=\"#cite_note-urlThe_10_Biggest-Selling_Drugs_That_Are_About_to_Lose_Their_Patent_-_DailyFinance-8\">&#91;8&#93;</a></sup> <a href=\"/wiki/Genome-wide_association_study\" title=\"Genome-wide association study\">GWAS</a> studies have linked the gene <a href=\"/wiki/CYP2C19\" title=\"CYP2C19\">CYP2C19</a> to those who cannot normally metabolize <a href=\"/wiki/Plavix\" class=\"mw-redirect\" title=\"Plavix\">Plavix</a>. Plavix is given to patients after receiving a <a href=\"/wiki/Coronary_stent\" title=\"Coronary stent\">stent in the coronary artery</a> to prevent clotting.\n</p><p>Stent clots almost always result in heart attack or sudden death, fortunately it only occurs in 1 or 2% of the population. That 1 or 2% are those with the CYP2C19 SNP.<sup id=\"cite_ref-pmid19706858_9-0\" class=\"reference\"><a href=\"#cite_note-pmid19706858-9\">&#91;9&#93;</a></sup> This finding has been applied in at least two hospitals, Scripps and Vanderbilt University, where patients who are candidates for heart stents are screened for the CYP2C19 variants.<sup id=\"cite_ref-isbn0-465-02550-1_10-0\" class=\"reference\"><a href=\"#cite_note-isbn0-465-02550-1-10\">&#91;10&#93;</a></sup>\n</p><p>Another newfound use of pharmacogenetics involves the use of Vitamin E. The Technion Israel Institute of Technology observed that vitamin E can be used to in certain genotypes to lower the risk of cardiovascular disease in patients with <a href=\"/wiki/Diabetes_mellitus\" title=\"Diabetes mellitus\">diabetes</a>, but in the same patients with another genotype, vitamin E can raise the risk of cardiovascular disease. A study was carried out, showing vitamin E is able to increase the function of <a href=\"/wiki/High-density_lipoprotein\" title=\"High-density lipoprotein\">HDL</a> in those with the genotype haptoglobin 2-2 who suffer from diabetes. HDL is a lipoprotein that removes cholesterol from the blood and is associated with a reduced risk of atherosclerosis and heart disease. However, if you have the misfortune to possess the genotype haptoglobin 2-1, the study shows that this same treatment can drastically decrease your HDL function and cause cardiovascular disease.<sup id=\"cite_ref-pmid21722898_11-0\" class=\"reference\"><a href=\"#cite_note-pmid21722898-11\">&#91;11&#93;</a></sup>\n</p><p>Pharmacogenetics is a rising concern in clinical oncology, because the therapeutic window of most anticancer drugs is narrow and patients with impaired ability to detoxify drugs will undergo life-threatening toxicities. In particular, genetic deregulations affecting genes coding for <a href=\"/wiki/Dihydropyrimidine_dehydrogenase\" title=\"Dihydropyrimidine dehydrogenase\">DPD</a>, <a href=\"/wiki/UGT1A1\" class=\"mw-redirect\" title=\"UGT1A1\">UGT1A1</a>, <a href=\"/wiki/TPMT\" class=\"mw-redirect\" title=\"TPMT\">TPMT</a>, <a href=\"/wiki/Cytidine_deaminase\" title=\"Cytidine deaminase\">CDA</a> and <a href=\"/wiki/CYP2D6\" title=\"CYP2D6\">CYP2D6</a> are now considered as critical issues for patients treated with 5-FU/capecitabine, irinotecan, mercaptopurine/azathioprine, gemcitabine/capecitabine/AraC and tamoxifen, respectively. The decision to use pharmacogenetic techniques is influenced by the relative costs of <a href=\"/wiki/Genotyping\" title=\"Genotyping\">genotyping</a> technologies and the cost of providing a treatment to a patient with an incompatible genotype. When available, phenotype-based approaches proved their usefulness while being cost-effective.<sup id=\"cite_ref-pmid20204365_12-0\" class=\"reference\"><a href=\"#cite_note-pmid20204365-12\">&#91;12&#93;</a></sup>\n</p><p>In the search for informative correlates of psychotropic drug response, pharmacogenetics has several advantages:<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup>\n</p>\n<ul><li>The genotype of an individual is essentially invariable and remains unaffected by the treatment itself.<sup class=\"noprint Inline-Template\" style=\"margin-left:0.1em; white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Please_clarify\" title=\"Wikipedia:Please clarify\"><span title=\"This is technically correct in that the genotype is invariable, but the phenotype determined via those genotypes is affected (often quite strongly) by treatment with inhibitors or inducers, and this really needs to be explained. Here&#39;s a case of how this plays out: let&#39;s say a patient has CYP2D6 genotypes that predict a CYP2D6 phenotype resulting in normal metabolism, but as this hypothetical patient is on fluoxetine (a potent CYP2D6 inhibitor), this result is quite likely not reflective of their actual state of CYP2D6 metabolism (which can be measured directly using dextromethorphan). (February 2016)\">clarification needed</span></a></i>&#93;</sup></li>\n<li>Molecular biology techniques provide an accurate assessment of the genotype of an individual.<sup class=\"noprint Inline-Template\" style=\"margin-left:0.1em; white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Avoid_weasel_words\" class=\"mw-redirect\" title=\"Wikipedia:Avoid weasel words\"><span title=\"Who says this? (February 2016)\">weasel&#160;words</span></a></i>&#93;</sup></li>\n<li>There has been a dramatic increase in the amount of genomic information that is available. This information provides the necessary data for comprehensive studies of individual genes and broad investigation of genome-wide variation.</li>\n<li>The ease of accessibility to genotype information through peripheral blood or saliva sampling and advances in molecular techniques has increased the feasibility of DNA collection and genotyping in large-scale clinical trials.</li></ul>\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=2\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The first observations of genetic variation in drug response date from the 1950s, involving the muscle relaxant <a href=\"/wiki/Suxamethonium_chloride\" title=\"Suxamethonium chloride\">suxamethonium chloride</a>, and drugs metabolized by <a href=\"/wiki/N-acetyltransferase\" title=\"N-acetyltransferase\">N-acetyltransferase</a>. One in 3500 <a href=\"/wiki/Caucasian_race\" title=\"Caucasian race\">Caucasians</a> has less efficient variant of the <a href=\"/wiki/Enzyme\" title=\"Enzyme\">enzyme</a> (<a href=\"/wiki/Butyrylcholinesterase\" title=\"Butyrylcholinesterase\">butyrylcholinesterase</a>) that <a href=\"/wiki/Metabolize\" class=\"mw-redirect\" title=\"Metabolize\">metabolizes</a> suxamethonium chloride.<sup id=\"cite_ref-pmid16968950_14-0\" class=\"reference\"><a href=\"#cite_note-pmid16968950-14\">&#91;14&#93;</a></sup> As a consequence, the drug\u2019s effect is prolonged, with slower recovery from surgical paralysis. Variation in the <a href=\"/wiki/N-acetyltransferase\" title=\"N-acetyltransferase\">N-acetyltransferase</a> gene divides people into \"slow acetylators\" and \"fast acetylators\", with very different <a href=\"/wiki/Mean_lifetime\" class=\"mw-redirect\" title=\"Mean lifetime\">half-lives</a> and <a href=\"/w/index.php?title=Blood_concentration&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Blood concentration (page does not exist)\">blood concentrations</a> of such important drugs as <a href=\"/wiki/Isoniazid\" title=\"Isoniazid\">isoniazid</a> (antituberculosis) and <a href=\"/wiki/Procainamide\" title=\"Procainamide\">procainamide</a> (antiarrhythmic). As part of the inborn system for clearing the body of <a href=\"/wiki/Xenobiotic\" title=\"Xenobiotic\">xenobiotics</a>, the <a href=\"/wiki/Cytochrome_P450_oxidase\" class=\"mw-redirect\" title=\"Cytochrome P450 oxidase\">cytochrome P450 oxidases</a> (CYPs) are heavily involved in <a href=\"/wiki/Drug_metabolism\" title=\"Drug metabolism\">drug metabolism</a>, and genetic variations in CYPs affect large populations.  One member of the CYP superfamily, <a href=\"/wiki/CYP2D6\" title=\"CYP2D6\">CYP2D6</a>, now has over 75 known allelic variations, some of which lead to no activity, and some to enhanced activity. An estimated 29% of people in parts of <a href=\"/wiki/East_Africa\" title=\"East Africa\">East Africa</a> may have multiple copies of the gene, and will therefore not be adequately treated with standard doses of drugs such as the painkiller <a href=\"/wiki/Codeine\" title=\"Codeine\">codeine</a> (which is activated by the enzyme). The first study using Genome-wide association studies (GWAS) linked age-related macular degeneration (AMD) with a SNP located on chromosome 1 that increased one\u2019s risk of AMD. AMD is the most common cause of blindness, affecting more than seven million Americans. Until this study in 2005, we only knew about the inflammation of the retinal tissue causing AMD, not the genes responsible.<sup id=\"cite_ref-isbn0-465-02550-1_10-1\" class=\"reference\"><a href=\"#cite_note-isbn0-465-02550-1-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span id=\"Thiopurines_and_TPMT_.28thiopurine_methyl_transferase.29\"></span><span class=\"mw-headline\" id=\"Thiopurines_and_TPMT_(thiopurine_methyl_transferase)\">Thiopurines and TPMT (thiopurine methyl transferase)</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=3\" title=\"Edit section: Thiopurines and TPMT (thiopurine methyl transferase)\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>One of the earliest tests for a genetic variation resulting in a clinically important consequence was on the enzyme <a href=\"/wiki/Thiopurine_methyltransferase\" title=\"Thiopurine methyltransferase\">thiopurine methyltransferase</a> (TPMT). TPMT metabolizes <a href=\"/wiki/6-mercaptopurine\" class=\"mw-redirect\" title=\"6-mercaptopurine\">6-mercaptopurine</a> and <a href=\"/wiki/Azathioprine\" title=\"Azathioprine\">azathioprine</a>, two <a href=\"/wiki/Thiopurine\" title=\"Thiopurine\">thiopurine</a> drugs used in a range of indications, from childhood <a href=\"/wiki/Leukemia\" title=\"Leukemia\">leukemia</a> to <a href=\"/wiki/Autoimmune_diseases\" class=\"mw-redirect\" title=\"Autoimmune diseases\">autoimmune diseases</a>. In people with a deficiency in TPMT activity, thiopurine metabolism must proceed by other pathways, one of which leads to the active thiopurine <a href=\"/wiki/Metabolite\" title=\"Metabolite\">metabolite</a> that is toxic to the bone marrow at high concentrations.\nDeficiency of TPMT affects a small proportion of people, though seriously. One in 300 people have two variant <a href=\"/wiki/Alleles\" class=\"mw-redirect\" title=\"Alleles\">alleles</a> and lack TPMT activity; these people need only 6-10% of the standard dose of the drug, and, if treated with the full dose, are at risk of severe <a href=\"/wiki/Bone_marrow_suppression\" title=\"Bone marrow suppression\">bone marrow suppression</a>. For them, <a href=\"/wiki/Genotype\" title=\"Genotype\">genotype</a> predicts clinical outcome, a prerequisite for an effective pharmacogenetic test. In 85-90% of affected people, this deficiency results from one of three common variant alleles.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> \nAround 10% of people are <a href=\"/wiki/Heterozygous\" class=\"mw-redirect\" title=\"Heterozygous\">heterozygous</a> \u2013 they carry one variant allele \u2013 and produce a reduced quantity of functional enzyme. Overall, they are at greater risk of adverse effects, although as individuals their <a href=\"/wiki/Genotype\" title=\"Genotype\">genotype</a> is not necessarily predictive of their clinical outcome, which makes the interpretation of a clinical test difficult. Recent research suggests that patients who are heterozygous may have a better response to treatment, which raises whether people who have two <a href=\"/wiki/Wild-type\" class=\"mw-redirect\" title=\"Wild-type\">wild-type</a> alleles could tolerate a higher therapeutic dose.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> \nThe US <a href=\"/wiki/Food_and_Drug_Administration\" title=\"Food and Drug Administration\">Food and Drug Administration</a> (FDA) have recently deliberated the inclusion of a recommendation for testing for TPMT deficiency to the prescribing information for <a href=\"/wiki/6-mercaptopurine\" class=\"mw-redirect\" title=\"6-mercaptopurine\">6-mercaptopurine</a> and <a href=\"/wiki/Azathioprine\" title=\"Azathioprine\">azathioprine</a>. The information previously carried the warning that inherited deficiency of the enzyme could increase the risk of severe bone marrow suppression. It now carries the recommendation that people who develop bone marrow suppression while receiving 6-mercaptopurine or azathioprine be tested for TPMT deficiency.<sup class=\"noprint Inline-Template Template-Fact\" style=\"white-space:nowrap;\">&#91;<i><a href=\"/wiki/Wikipedia:Citation_needed\" title=\"Wikipedia:Citation needed\"><span title=\"No source (February 2016)\">citation needed</span></a></i>&#93;</sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Hepatitis_C\">Hepatitis C</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=4\" title=\"Edit section: Hepatitis C\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A polymorphism near a human interferon gene is predictive of the effectiveness of an artificial interferon treatment for Hepatitis C. For genotype 1 hepatitis C treated with <a href=\"/wiki/Pegylated_interferon-alpha-2a\" class=\"mw-redirect\" title=\"Pegylated interferon-alpha-2a\">Pegylated interferon-alpha-2a</a> or <a href=\"/wiki/Pegylated_interferon-alpha-2b\" class=\"mw-redirect\" title=\"Pegylated interferon-alpha-2b\">Pegylated interferon-alpha-2b</a> (brand names Pegasys or PEG-Intron) combined with <a href=\"/wiki/Ribavirin\" title=\"Ribavirin\">ribavirin</a>, it has been shown that genetic polymorphisms near the human IL28B gene, encoding interferon lambda 3, are associated with significant differences in response to the treatment.<sup id=\"cite_ref-pmid19684573_17-0\" class=\"reference\"><a href=\"#cite_note-pmid19684573-17\">&#91;17&#93;</a></sup> Genotype 1 hepatitis C patients carrying certain genetic variant alleles near the IL28B gene are more probable to achieve sustained virological response after the treatment than others, and demonstrated that the same genetic variants are also associated with the natural clearance of the genotype 1 hepatitis C virus.<sup id=\"cite_ref-pmid19759533_18-0\" class=\"reference\"><a href=\"#cite_note-pmid19759533-18\">&#91;18&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Integrating_into_the_health_care_system\">Integrating into the health care system</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=5\" title=\"Edit section: Integrating into the health care system\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Despite the many successes, most drugs are not tested using GWAS. However, it is estimated that over 25% of common medication have some type of genetic information that could be used in the medical field.<sup id=\"cite_ref-pmid18657016_19-0\" class=\"reference\"><a href=\"#cite_note-pmid18657016-19\">&#91;19&#93;</a></sup> If the use of <a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">personalized medicine</a> is widely adopted and used, it will make medical trials more efficient. This will lower the costs that come about due to adverse drug side effects and prescription of drugs that have been proven ineffective in certain genotypes. It is very costly when a clinical trial is put to a stop by licensing authorities because of the small population who experiences adverse drug reactions. With the new push for pharmacogenetics, it is possible to develop and license a drug specifically intended for those who are the small population genetically at risk for adverse side effects.\n<sup id=\"cite_ref-Corrigan_2010_20-0\" class=\"reference\"><a href=\"#cite_note-Corrigan_2010-20\">&#91;20&#93;</a></sup>\n</p><p>The ability to test and analyze an individual\u2019s DNA to determine if the body can break down certain drugs through the biochemical pathways has application in all fields of medicine. Pharmacogenetics gives those in the health care industry a potential solution to help prevent the significant number of deaths that occur each year due to drug reactions and side effects. The companies or laboratories that perform this testing can do so across all categories or drugs whether it be for high blood pressure, gastrointestinal, urological, psychotropic or anti-anxiety drugs. Results can be presented showing which drugs the body is capable of breaking down normally versus the drugs the body cannot break down normally. This test only needs to be done once and can provide valuable information such as a summary of an individual\u2019s genetic <a href=\"/wiki/Single-nucleotide_polymorphism\" title=\"Single-nucleotide polymorphism\">polymorphisms</a>, which could help in a situation such as being a patient in the emergency room.<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup> As pharmacogenetics continues to gain acceptance in clinical practice, when to utilize pharmacogenetics will be of importance in advancing patient care.<sup id=\"cite_ref-22\" class=\"reference\"><a href=\"#cite_note-22\">&#91;22&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Technological_advances\">Technological advances</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=6\" title=\"Edit section: Technological advances\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>As the cost per genetic test decreases, the development of personalized drug therapies will increase.<sup id=\"cite_ref-pmid17168846_23-0\" class=\"reference\"><a href=\"#cite_note-pmid17168846-23\">&#91;23&#93;</a></sup> Technology now allows for genetic analysis of hundreds of target genes involved in medication metabolism and response in less than 24 hours for under $1,000.  This a huge step towards bringing pharmacogenetic technology into everyday medical decisions. Likewise, companies like <a href=\"/wiki/DeCODE_genetics\" title=\"DeCODE genetics\">deCODE genetics</a>, <a rel=\"nofollow\" class=\"external text\" href=\"https://rxight.com\">MD Labs Pharmacogenetics</a>, <a href=\"/wiki/Navigenics\" title=\"Navigenics\">Navigenics</a> and <a href=\"/wiki/23andMe\" title=\"23andMe\">23andMe</a> offer genome scans. The companies use the same <a href=\"/wiki/Genotyping\" title=\"Genotyping\">genotyping</a> chips that are used in GWAS studies and provide customers with a write-up of individual risk for various traits and diseases and testing for 500,000 known SNPs. Costs range from $995 to $2500 and include updates with new data from studies as they become available. The more expensive packages even included a telephone session with a genetics counselor to discuss the results.<sup id=\"cite_ref-isbn0-465-02550-1_10-2\" class=\"reference\"><a href=\"#cite_note-isbn0-465-02550-1-10\">&#91;10&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Ethics\">Ethics</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=7\" title=\"Edit section: Ethics\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Pharmacogenetics has become a controversial issue in the area of bioethics. It's a new topic to the medical field, as well as the public. This new technique will have a huge impact on society, influencing the treatment of both common and rare diseases. As a new topic in the medical field the ethics behind it are still not clear. However, ethical issues and their possible solutions are already being addressed.\n</p><p>There are three main ethical issues that have risen from pharmacogenetics. First, would there be a type equity at both drug development and the accessibility to tests.<sup id=\"cite_ref-Breckenridge_24-0\" class=\"reference\"><a href=\"#cite_note-Breckenridge-24\">&#91;24&#93;</a></sup> The concern of accessibility to the test is whether it is going to be available directly to patients via the internet, or over the counter. The second concern regards the confidentiality of storage and usage of genetic information.<sup id=\"cite_ref-Corrigan_25-0\" class=\"reference\"><a href=\"#cite_note-Corrigan-25\">&#91;25&#93;</a></sup> \nThirdly, would patients have the control over being tested.\n</p><p>One concern that has risen is the ethical decision health providers must take with respect to educating the patient of the risks and benefits of medicine developed by this new technology. Pharmacogenetics is a new process that may increase the benefits of medicine while decreasing the risk.  However clinicians have been unsuccessful in educating patients regarding the concept of benefits over risk. The Nuffield Council reported that patients and health professionals have adequate information about pharmacogenetics tests and medicine.<sup id=\"cite_ref-Corrigan_25-1\" class=\"reference\"><a href=\"#cite_note-Corrigan-25\">&#91;25&#93;</a></sup> \nHealth care providers will also encounter an ethical decision in deciding to tell their patients that only certain individuals will benefit from the new medicine due to their genetic make-up.<sup id=\"cite_ref-Breckenridge_24-1\" class=\"reference\"><a href=\"#cite_note-Breckenridge-24\">&#91;24&#93;</a></sup>  Another ethical concern is that patients who have not taken the test be able to have access to this type of medicine. If access is given by the doctor the medicine could negatively impact the patient's health. The ethical issues behind pharmacogenetics tests, as well as medicine, are still a concern and policies will need to be implemented in the future.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=8\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Chemogenomics\" title=\"Chemogenomics\">Chemogenomics</a></li>\n<li><a href=\"/wiki/Personalized_medicine\" title=\"Personalized medicine\">Personalized medicine</a></li>\n<li><a href=\"/wiki/Pharmacovigilance\" title=\"Pharmacovigilance\">Pharmacovigilance</a></li>\n<li><a href=\"/wiki/Structural_genomics\" title=\"Structural genomics\">Structural genomics</a></li>\n<li><a href=\"/wiki/Toxicogenomics\" title=\"Toxicogenomics\">Toxicogenomics</a></li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=9\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-Klotz-2007-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Klotz-2007_1-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Klotz, U. (2007). \"The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications\". <i>Clin Pharmacokinet</i>. <b>46</b> (4): 271\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2165/00003088-200746040-00001\">10.2165/00003088-200746040-00001</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17375979\">17375979</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Pharmacokinet&amp;rft.atitle=The+role+of+pharmacogenetics+in+the+metabolism+of+antiepileptic+drugs%3A+pharmacokinetic+and+therapeutic+implications.&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=271-9&amp;rft.date=2007&amp;rft_id=info%3Adoi%2F10.2165%2F00003088-200746040-00001&amp;rft_id=info%3Apmid%2F17375979&amp;rft.aulast=Klotz&amp;rft.aufirst=U.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-2\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://pharmacy.unc.edu/research/centers/cpit/\">\"Center for Pharmacogenomics and Individualized Therapy\"</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2017-03-08</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Center+for+Pharmacogenomics+and+Individualized+Therapy&amp;rft_id=https%3A%2F%2Fpharmacy.unc.edu%2Fresearch%2Fcenters%2Fcpit%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid10866212-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid10866212_3-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Roses AD (June 2000). \"Pharmacogenetics and the practice of medicine\". <i>Nature</i>. <b>405</b> (6788): 857\u201365. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/35015728\">10.1038/35015728</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10866212\">10866212</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Pharmacogenetics+and+the+practice+of+medicine&amp;rft.volume=405&amp;rft.issue=6788&amp;rft.pages=857-65&amp;rft.date=2000-06&amp;rft_id=info%3Adoi%2F10.1038%2F35015728&amp;rft_id=info%3Apmid%2F10866212&amp;rft.au=Roses+AD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Syn NL, Yong WP, Lee SC, Goh BC (2015-01-01). \"Genetic factors affecting drug disposition in Asian cancer patients\". <i>Expert Opinion on Drug Metabolism &amp; Toxicology</i>. <b>11</b> (12): 1879\u201392. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1517/17425255.2015.1108964\">10.1517/17425255.2015.1108964</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26548636\">26548636</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Opinion+on+Drug+Metabolism+%26+Toxicology&amp;rft.atitle=Genetic+factors+affecting+drug+disposition+in+Asian+cancer+patients&amp;rft.volume=11&amp;rft.issue=12&amp;rft.pages=1879-92&amp;rft.date=2015-01-01&amp;rft_id=info%3Adoi%2F10.1517%2F17425255.2015.1108964&amp;rft_id=info%3Apmid%2F26548636&amp;rft.aulast=Syn&amp;rft.aufirst=NL&amp;rft.au=Yong%2C+WP&amp;rft.au=Lee%2C+SC&amp;rft.au=Goh%2C+BC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid9555760-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid9555760_5-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lazarou J, Pomeranz BH, Corey PN (April 1998). \"Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies\". <i>JAMA</i>. <b>279</b> (15): 1200\u20135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.279.15.1200\">10.1001/jama.279.15.1200</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/9555760\">9555760</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Incidence+of+adverse+drug+reactions+in+hospitalized+patients%3A+a+meta-analysis+of+prospective+studies&amp;rft.volume=279&amp;rft.issue=15&amp;rft.pages=1200-5&amp;rft.date=1998-04&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.279.15.1200&amp;rft_id=info%3Apmid%2F9555760&amp;rft.aulast=Lazarou&amp;rft.aufirst=J&amp;rft.au=Pomeranz%2C+BH&amp;rft.au=Corey%2C+PN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Ingelman-Sundberg_2005-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Ingelman-Sundberg_2005_6-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ingelman-Sundberg M, Rodriguez-Antona C (August 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1569528\">\"Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy\"</a>. <i>Philos. Trans. R. Soc. Lond. B Biol. Sci</i>. <b>360</b> (1460): 1563\u201370. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1098/rstb.2005.1685\">10.1098/rstb.2005.1685</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1569528\">1569528</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16096104\">16096104</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Philos.+Trans.+R.+Soc.+Lond.+B+Biol.+Sci.&amp;rft.atitle=Pharmacogenetics+of+drug-metabolizing+enzymes%3A+implications+for+a+safer+and+more+effective+drug+therapy&amp;rft.volume=360&amp;rft.issue=1460&amp;rft.pages=1563-70&amp;rft.date=2005-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1569528&amp;rft_id=info%3Apmid%2F16096104&amp;rft_id=info%3Adoi%2F10.1098%2Frstb.2005.1685&amp;rft.aulast=Ingelman-Sundberg&amp;rft.aufirst=M&amp;rft.au=Rodriguez-Antona%2C+C&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1569528&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20205659-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20205659_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kirchheiner J, Seeringer A, Viviani R (2010). \"Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?\". <i>Curr. Pharm. Des</i>. <b>16</b> (2): 136\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2174/138161210790112728\">10.2174/138161210790112728</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20205659\">20205659</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr.+Pharm.+Des.&amp;rft.atitle=Pharmacogenetics+in+psychiatry--a+useful+clinical+tool+or+wishful+thinking+for+the+future%3F&amp;rft.volume=16&amp;rft.issue=2&amp;rft.pages=136-44&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.2174%2F138161210790112728&amp;rft_id=info%3Apmid%2F20205659&amp;rft.aulast=Kirchheiner&amp;rft.aufirst=J&amp;rft.au=Seeringer%2C+A&amp;rft.au=Viviani%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-urlThe_10_Biggest-Selling_Drugs_That_Are_About_to_Lose_Their_Patent_-_DailyFinance-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-urlThe_10_Biggest-Selling_Drugs_That_Are_About_to_Lose_Their_Patent_-_DailyFinance_8-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Alazraki M (2011). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.dailyfinance.com/2011/02/27/top-selling-drugs-are-about-to-lose-patent-protection-ready/\">\"The 10 Biggest-Selling Drugs That Are About to Lose Their Patent\"</a>. DailyFinance<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2012-05-06</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=The+10+Biggest-Selling+Drugs+That+Are+About+to+Lose+Their+Patent&amp;rft.pub=DailyFinance&amp;rft.date=2011&amp;rft.au=Alazraki+M&amp;rft_id=http%3A%2F%2Fwww.dailyfinance.com%2F2011%2F02%2F27%2Ftop-selling-drugs-are-about-to-lose-patent-protection-ready%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19706858-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19706858_9-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA (August 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3641569\">\"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy\"</a>. <i>JAMA</i>. <b>302</b> (8): 849\u201357. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.2009.1232\">10.1001/jama.2009.1232</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3641569\">3641569</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19706858\">19706858</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Association+of+cytochrome+P450+2C19+genotype+with+the+antiplatelet+effect+and+clinical+efficacy+of+clopidogrel+therapy&amp;rft.volume=302&amp;rft.issue=8&amp;rft.pages=849-57&amp;rft.date=2009-08&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3641569&amp;rft_id=info%3Apmid%2F19706858&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2009.1232&amp;rft.aulast=Shuldiner&amp;rft.aufirst=AR&amp;rft.au=O%27Connell%2C+JR&amp;rft.au=Bliden%2C+KP&amp;rft.au=Gandhi%2C+A&amp;rft.au=Ryan%2C+K&amp;rft.au=Horenstein%2C+RB&amp;rft.au=Damcott%2C+CM&amp;rft.au=Pakyz%2C+R&amp;rft.au=Tantry%2C+US&amp;rft.au=Gibson%2C+Q&amp;rft.au=Pollin%2C+TI&amp;rft.au=Post%2C+W&amp;rft.au=Parsa%2C+A&amp;rft.au=Mitchell%2C+BD&amp;rft.au=Faraday%2C+N&amp;rft.au=Herzog%2C+W&amp;rft.au=Gurbel%2C+PA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3641569&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-isbn0-465-02550-1-10\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-isbn0-465-02550-1_10-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-isbn0-465-02550-1_10-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-isbn0-465-02550-1_10-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\"><i>The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care</i>. New York: Basic Books. 2012. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-465-02550-1\" title=\"Special:BookSources/0-465-02550-1\">0-465-02550-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+Creative+Destruction+of+Medicine%3A+How+the+Digital+Revolution+Will+Create+Better+Health+Care&amp;rft.place=New+York&amp;rft.pub=Basic+Books&amp;rft.date=2012&amp;rft.isbn=0-465-02550-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21722898-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid21722898_11-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Farbstein D, Blum S, Pollak M, Asaf R, Viener HL, Lache O, Asleh R, Miller-Lotan R, Barkay I, Star M, Schwartz A, Kalet-Littman S, Ozeri D, Vaya J, Tavori H, Vardi M, Laor A, Bucher SE, Anbinder Y, Moskovich D, Abbas N, Perry N, Levy Y, Levy AP (November 2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200506\">\"Vitamin E therapy results in a reduction in HDL function in individuals with diabetes and the haptoglobin 2-1 genotype\"</a>. <i>Atherosclerosis</i>. <b>219</b> (1): 240\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.atherosclerosis.2011.06.005\">10.1016/j.atherosclerosis.2011.06.005</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200506\">3200506</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21722898\">21722898</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Atherosclerosis&amp;rft.atitle=Vitamin+E+therapy+results+in+a+reduction+in+HDL+function+in+individuals+with+diabetes+and+the+haptoglobin+2-1+genotype&amp;rft.volume=219&amp;rft.issue=1&amp;rft.pages=240-4&amp;rft.date=2011-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3200506&amp;rft_id=info%3Apmid%2F21722898&amp;rft_id=info%3Adoi%2F10.1016%2Fj.atherosclerosis.2011.06.005&amp;rft.aulast=Farbstein&amp;rft.aufirst=D&amp;rft.au=Blum%2C+S&amp;rft.au=Pollak%2C+M&amp;rft.au=Asaf%2C+R&amp;rft.au=Viener%2C+HL&amp;rft.au=Lache%2C+O&amp;rft.au=Asleh%2C+R&amp;rft.au=Miller-Lotan%2C+R&amp;rft.au=Barkay%2C+I&amp;rft.au=Star%2C+M&amp;rft.au=Schwartz%2C+A&amp;rft.au=Kalet-Littman%2C+S&amp;rft.au=Ozeri%2C+D&amp;rft.au=Vaya%2C+J&amp;rft.au=Tavori%2C+H&amp;rft.au=Vardi%2C+M&amp;rft.au=Laor%2C+A&amp;rft.au=Bucher%2C+SE&amp;rft.au=Anbinder%2C+Y&amp;rft.au=Moskovich%2C+D&amp;rft.au=Abbas%2C+N&amp;rft.au=Perry%2C+N&amp;rft.au=Levy%2C+Y&amp;rft.au=Levy%2C+AP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3200506&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid20204365-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid20204365_12-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang CG, Ciccolini J, Blesius A, Dahan L, Bagarry-Liegey D, Brunet C, Varoquaux A, Frances N, Marouani H, Giovanni A, Ferri-Dessens RM, Chefrour M, Favre R, Duffaud F, Seitz JF, Zanaret M, Lacarelle B, Mercier C (January 2011). \"DPD-based adaptive dosing of 5-FU in patients with head and neck cancer: impact on treatment efficacy and toxicity\". <i>Cancer Chemother. Pharmacol</i>. <b>67</b> (1): 49\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s00280-010-1282-4\">10.1007/s00280-010-1282-4</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20204365\">20204365</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Chemother.+Pharmacol.&amp;rft.atitle=DPD-based+adaptive+dosing+of+5-FU+in+patients+with+head+and+neck+cancer%3A+impact+on+treatment+efficacy+and+toxicity&amp;rft.volume=67&amp;rft.issue=1&amp;rft.pages=49-56&amp;rft.date=2011-01&amp;rft_id=info%3Adoi%2F10.1007%2Fs00280-010-1282-4&amp;rft_id=info%3Apmid%2F20204365&amp;rft.aulast=Yang&amp;rft.aufirst=CG&amp;rft.au=Ciccolini%2C+J&amp;rft.au=Blesius%2C+A&amp;rft.au=Dahan%2C+L&amp;rft.au=Bagarry-Liegey%2C+D&amp;rft.au=Brunet%2C+C&amp;rft.au=Varoquaux%2C+A&amp;rft.au=Frances%2C+N&amp;rft.au=Marouani%2C+H&amp;rft.au=Giovanni%2C+A&amp;rft.au=Ferri-Dessens%2C+RM&amp;rft.au=Chefrour%2C+M&amp;rft.au=Favre%2C+R&amp;rft.au=Duffaud%2C+F&amp;rft.au=Seitz%2C+JF&amp;rft.au=Zanaret%2C+M&amp;rft.au=Lacarelle%2C+B&amp;rft.au=Mercier%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Malhotra AK (2010). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.psychiatrictimes.com/neuropsychiatry/content/article/10168/1550787\">\"The state of pharmacogenetics\"</a>. <i>Psychiatr Times</i>. <b>27</b> (4): 38\u201341, 62.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Psychiatr+Times&amp;rft.atitle=The+state+of+pharmacogenetics&amp;rft.volume=27&amp;rft.issue=4&amp;rft.pages=38-41%2C+62&amp;rft.date=2010&amp;rft.au=Malhotra+AK&amp;rft_id=http%3A%2F%2Fwww.psychiatrictimes.com%2Fneuropsychiatry%2Fcontent%2Farticle%2F10168%2F1550787&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid16968950-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid16968950_14-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gardiner SJ, Begg EJ (September 2006). \"Pharmacogenetics, drug-metabolizing enzymes, and clinical practice\". <i>Pharmacol. Rev</i>. <b>58</b> (3): 521\u201390. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1124/pr.58.3.6\">10.1124/pr.58.3.6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16968950\">16968950</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacol.+Rev.&amp;rft.atitle=Pharmacogenetics%2C+drug-metabolizing+enzymes%2C+and+clinical+practice&amp;rft.volume=58&amp;rft.issue=3&amp;rft.pages=521-90&amp;rft.date=2006-09&amp;rft_id=info%3Adoi%2F10.1124%2Fpr.58.3.6&amp;rft_id=info%3Apmid%2F16968950&amp;rft.aulast=Gardiner&amp;rft.aufirst=SJ&amp;rft.au=Begg%2C+EJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Genetic Science Learning Center. <a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20090202101452/http://learn.genetics.utah.edu/content/health/pharma/intro/\">\"Your Doctor's New Genetic Tools\"</a>. Lern.Genetics. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://learn.genetics.utah.edu/content/health/pharma/intro/\">the original</a> on 2 February 2009<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">15 April</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Your+Doctor%27s+New+Genetic+Tools.&amp;rft.pub=Lern.Genetics&amp;rft.au=Genetic+Science+Learning+Center&amp;rft_id=http%3A%2F%2Flearn.genetics.utah.edu%2Fcontent%2Fhealth%2Fpharma%2Fintro%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"https://web.archive.org/web/20050409170510/http://discoverysedge.mayo.edu/pharmacogenomics/\">\"Pharmacogenomics: Personalizing Medicine\"</a>. <i>Discovery's Edge</i>. Mayo Clinic. Archived from <a rel=\"nofollow\" class=\"external text\" href=\"http://discoverysedge.mayo.edu/pharmacogenomics/\">the original</a> on April 9, 2005<span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">April 15,</span> 2012</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Discovery%27s+Edge&amp;rft.atitle=Pharmacogenomics%3A+Personalizing+Medicine&amp;rft_id=http%3A%2F%2Fdiscoverysedge.mayo.edu%2Fpharmacogenomics%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19684573-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19684573_17-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB (September 2009). \"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance\". <i>Nature</i>. <b>461</b> (7262): 399\u2013401. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature08309\">10.1038/nature08309</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19684573\">19684573</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Genetic+variation+in+IL28B+predicts+hepatitis+C+treatment-induced+viral+clearance&amp;rft.volume=461&amp;rft.issue=7262&amp;rft.pages=399-401&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1038%2Fnature08309&amp;rft_id=info%3Apmid%2F19684573&amp;rft.aulast=Ge&amp;rft.aufirst=D&amp;rft.au=Fellay%2C+J&amp;rft.au=Thompson%2C+AJ&amp;rft.au=Simon%2C+JS&amp;rft.au=Shianna%2C+KV&amp;rft.au=Urban%2C+TJ&amp;rft.au=Heinzen%2C+EL&amp;rft.au=Qiu%2C+P&amp;rft.au=Bertelsen%2C+AH&amp;rft.au=Muir%2C+AJ&amp;rft.au=Sulkowski%2C+M&amp;rft.au=McHutchison%2C+JG&amp;rft.au=Goldstein%2C+DB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid19759533-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid19759533_18-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (October 2009). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3172006\">\"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus\"</a>. <i>Nature</i>. <b>461</b> (7265): 798\u2013801. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature08463\">10.1038/nature08463</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3172006\">3172006</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19759533\">19759533</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Genetic+variation+in+IL28B+and+spontaneous+clearance+of+hepatitis+C+virus&amp;rft.volume=461&amp;rft.issue=7265&amp;rft.pages=798-801&amp;rft.date=2009-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3172006&amp;rft_id=info%3Apmid%2F19759533&amp;rft_id=info%3Adoi%2F10.1038%2Fnature08463&amp;rft.aulast=Thomas&amp;rft.aufirst=DL&amp;rft.au=Thio%2C+CL&amp;rft.au=Martin%2C+MP&amp;rft.au=Qi%2C+Y&amp;rft.au=Ge%2C+D&amp;rft.au=O%27Huigin%2C+C&amp;rft.au=Kidd%2C+J&amp;rft.au=Kidd%2C+K&amp;rft.au=Khakoo%2C+SI&amp;rft.au=Alexander%2C+G&amp;rft.au=Goedert%2C+JJ&amp;rft.au=Kirk%2C+GD&amp;rft.au=Donfield%2C+SM&amp;rft.au=Rosen%2C+HR&amp;rft.au=Tobler%2C+LH&amp;rft.au=Busch%2C+MP&amp;rft.au=McHutchison%2C+JG&amp;rft.au=Goldstein%2C+DB&amp;rft.au=Carrington%2C+M&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3172006&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid18657016-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid18657016_19-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Frueh FW, Amur S, Mummaneni P, Epstein RS, Aubert RE, DeLuca TM, Verbrugge RR, Burckart GJ, Lesko LJ (August 2008). \"Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use\". <i>Pharmacotherapy</i>. <b>28</b> (8): 992\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1592/phco.28.8.992\">10.1592/phco.28.8.992</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18657016\">18657016</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacotherapy&amp;rft.atitle=Pharmacogenomic+biomarker+information+in+drug+labels+approved+by+the+United+States+food+and+drug+administration%3A+prevalence+of+related+drug+use&amp;rft.volume=28&amp;rft.issue=8&amp;rft.pages=992-8&amp;rft.date=2008-08&amp;rft_id=info%3Adoi%2F10.1592%2Fphco.28.8.992&amp;rft_id=info%3Apmid%2F18657016&amp;rft.aulast=Frueh&amp;rft.aufirst=FW&amp;rft.au=Amur%2C+S&amp;rft.au=Mummaneni%2C+P&amp;rft.au=Epstein%2C+RS&amp;rft.au=Aubert%2C+RE&amp;rft.au=DeLuca%2C+TM&amp;rft.au=Verbrugge%2C+RR&amp;rft.au=Burckart%2C+GJ&amp;rft.au=Lesko%2C+LJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Corrigan_2010-20\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Corrigan_2010_20-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Corrigan OP (2011). \"Personalized Medicine in a Consumer Age\". <i>Current Pharmacogenomics and Personalized Medicine</i>. <b>9</b>: 168\u2013176. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2174/187569211796957566\">10.2174/187569211796957566</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Pharmacogenomics+and+Personalized+Medicine&amp;rft.atitle=Personalized+Medicine+in+a+Consumer+Age&amp;rft.volume=9&amp;rft.pages=168-176&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.2174%2F187569211796957566&amp;rft.au=Corrigan+OP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\">Director, Dr Soram Khalsa Medical; Institute, East-West Medical Research (2015-06-28). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.huffingtonpost.com/dr-soram-khalsa/pharmacogenetics-what-it-is-_b_7683164.html\">\"Pharmacogenetics: What It Is And Why You Need to Know\"</a>. <i>The Huffington Post</i><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2016-10-05</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=The+Huffington+Post&amp;rft.atitle=Pharmacogenetics%3A+What+It+Is+And+Why+You+Need+to+Know&amp;rft.date=2015-06-28&amp;rft.aulast=Director&amp;rft.aufirst=Dr+Soram+Khalsa+Medical&amp;rft.au=Institute%2C+East-West+Medical+Research&amp;rft_id=http%3A%2F%2Fwww.huffingtonpost.com%2Fdr-soram-khalsa%2Fpharmacogenetics-what-it-is-_b_7683164.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-22\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Alzghari SK, Blakeney L, Rambaran KA (May 2017). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5493454\">\"Proposal for a Pharmacogenetic Decision Algorithm\"</a>. <i>Cureus</i>. <b>9</b> (5): e1289. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7759/cureus.1289\">10.7759/cureus.1289</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC5493454\">5493454</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/28680777\">28680777</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cureus&amp;rft.atitle=Proposal+for+a+Pharmacogenetic+Decision+Algorithm&amp;rft.volume=9&amp;rft.issue=5&amp;rft.pages=e1289&amp;rft.date=2017-05&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5493454&amp;rft_id=info%3Apmid%2F28680777&amp;rft_id=info%3Adoi%2F10.7759%2Fcureus.1289&amp;rft.aulast=Alzghari&amp;rft.aufirst=SK&amp;rft.au=Blakeney%2C+L&amp;rft.au=Rambaran%2C+KA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5493454&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid17168846-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-pmid17168846_23-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Paul NW, Fangerau H (December 2006). \"Why should we bother? Ethical and social issues in individualized medicine\". <i>Curr Drug Targets</i>. <b>7</b> (12): 1721\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.2174/138945006779025428\">10.2174/138945006779025428</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17168846\">17168846</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Curr+Drug+Targets&amp;rft.atitle=Why+should+we+bother%3F+Ethical+and+social+issues+in+individualized+medicine&amp;rft.volume=7&amp;rft.issue=12&amp;rft.pages=1721-7&amp;rft.date=2006-12&amp;rft_id=info%3Adoi%2F10.2174%2F138945006779025428&amp;rft_id=info%3Apmid%2F17168846&amp;rft.aulast=Paul&amp;rft.aufirst=NW&amp;rft.au=Fangerau%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Breckenridge-24\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Breckenridge_24-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Breckenridge_24-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Breckenridge A, Lindpaintner K, Lipton P, McLeod H, Rothstein M, Wallace H (September 2004). \"Pharmacogenetics: ethical problems and solutions\". <i>Nat. Rev. Genet</i>. <b>5</b> (9): 676\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrg1431\">10.1038/nrg1431</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15372090\">15372090</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nat.+Rev.+Genet.&amp;rft.atitle=Pharmacogenetics%3A+ethical+problems+and+solutions&amp;rft.volume=5&amp;rft.issue=9&amp;rft.pages=676-80&amp;rft.date=2004-09&amp;rft_id=info%3Adoi%2F10.1038%2Fnrg1431&amp;rft_id=info%3Apmid%2F15372090&amp;rft.aulast=Breckenridge&amp;rft.aufirst=A&amp;rft.au=Lindpaintner%2C+K&amp;rft.au=Lipton%2C+P&amp;rft.au=McLeod%2C+H&amp;rft.au=Rothstein%2C+M&amp;rft.au=Wallace%2C+H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Corrigan-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Corrigan_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Corrigan_25-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Corrigan OP (March 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1734105\">\"Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report\"</a>. <i>J. Med. Ethics</i>. <b>31</b> (3): 144\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/jme.2004.007229\">10.1136/jme.2004.007229</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1734105\">1734105</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15738433\">15738433</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Med.+Ethics&amp;rft.atitle=Pharmacogenetics%2C+ethical+issues%3A+review+of+the+Nuffield+Council+on+Bioethics+Report&amp;rft.volume=31&amp;rft.issue=3&amp;rft.pages=144-8&amp;rft.date=2005-03&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1734105&amp;rft_id=info%3Apmid%2F15738433&amp;rft_id=info%3Adoi%2F10.1136%2Fjme.2004.007229&amp;rft.au=Corrigan+OP&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1734105&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n<h2><span class=\"mw-headline\" id=\"Further_reading\">Further reading</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=10\" title=\"Edit section: Further reading\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<style data-mw-deduplicate=\"TemplateStyles:r853264625\">.mw-parser-output .refbegin{font-size:90%;margin-bottom:0.5em}.mw-parser-output .refbegin-hanging-indents>ul{list-style-type:none;margin-left:0}.mw-parser-output .refbegin-hanging-indents>ul>li,.mw-parser-output .refbegin-hanging-indents>dl>dd{margin-left:0;padding-left:3.2em;text-indent:-3.2em;list-style:none}.mw-parser-output .refbegin-100{font-size:100%}</style><div class=\"refbegin columns references-column-count references-column-count-2\" style=\"-moz-column-count: 2; -webkit-column-count: 2; column-count: 2;\">\n<ul><li><cite class=\"citation journal\">Abbott A (October 2003). \"With your genes? Take one of these, three times a day\". <i>Nature</i>. <b>425</b> (6960): 760\u20132. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/425760a\">10.1038/425760a</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14574377\">14574377</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=With+your+genes%3F+Take+one+of+these%2C+three+times+a+day&amp;rft.volume=425&amp;rft.issue=6960&amp;rft.pages=760-2&amp;rft.date=2003-10&amp;rft_id=info%3Adoi%2F10.1038%2F425760a&amp;rft_id=info%3Apmid%2F14574377&amp;rft.au=Abbott+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Evans WE, McLeod HL (February 2003). \"Pharmacogenomics \u2013 drug disposition, drug targets, and side effects\". <i>N. Engl. J. Med</i>. <b>348</b> (6): 538\u201349. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMra020526\">10.1056/NEJMra020526</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12571262\">12571262</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=N.+Engl.+J.+Med.&amp;rft.atitle=Pharmacogenomics+%E2%80%93+drug+disposition%2C+drug+targets%2C+and+side+effects&amp;rft.volume=348&amp;rft.issue=6&amp;rft.pages=538-49&amp;rft.date=2003-02&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra020526&amp;rft_id=info%3Apmid%2F12571262&amp;rft.aulast=Evans&amp;rft.aufirst=WE&amp;rft.au=McLeod%2C+HL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Phillips KA, Veenstra DL, Oren E, Lee JK, Sadee W (November 2001). \"Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review\". <i>JAMA</i>. <b>286</b> (18): 2270\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.286.18.2270\">10.1001/jama.286.18.2270</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/11710893\">11710893</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Potential+role+of+pharmacogenomics+in+reducing+adverse+drug+reactions%3A+a+systematic+review&amp;rft.volume=286&amp;rft.issue=18&amp;rft.pages=2270-9&amp;rft.date=2001-11&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.286.18.2270&amp;rft_id=info%3Apmid%2F11710893&amp;rft.aulast=Phillips&amp;rft.aufirst=KA&amp;rft.au=Veenstra%2C+DL&amp;rft.au=Oren%2C+E&amp;rft.au=Lee%2C+JK&amp;rft.au=Sadee%2C+W&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li>\n<li><cite class=\"citation journal\">Weinshilboum R (February 2003). \"Inheritance and drug response\". <i>The New England Journal of Medicine</i>. <b>348</b> (6): 529\u201337. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJMra020021\">10.1056/NEJMra020021</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12571261\">12571261</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+England+Journal+of+Medicine&amp;rft.atitle=Inheritance+and+drug+response&amp;rft.volume=348&amp;rft.issue=6&amp;rft.pages=529-37&amp;rft.date=2003-02&amp;rft_id=info%3Adoi%2F10.1056%2FNEJMra020021&amp;rft_id=info%3Apmid%2F12571261&amp;rft.aulast=Weinshilboum&amp;rft.aufirst=R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3APharmacogenetics\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></li></ul>\n</div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Pharmacogenetics&amp;action=edit&amp;section=11\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml\">Pharmacogenomics: Medicine and the new genetics</a> from the Human Genome Project</li>\n<li><a rel=\"nofollow\" class=\"external text\" href=\"https://www.springer.com/humana+press/pharmacology+and+toxicology/book/978-1-58829-887-4\"><i>Pharmacogenomics in Drug Discovery and Development</i></a>, a book on pharmacogenomics , diseases, personalized medicine, and therapeutics</li></ul>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Concepts_in_pharmacology\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\" style=\"background:#efefef\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Pharmacology\" title=\"Template:Pharmacology\"><abbr title=\"View this template\" style=\";background:#efefef;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Pharmacology\" title=\"Template talk:Pharmacology\"><abbr title=\"Discuss this template\" style=\";background:#efefef;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Pharmacology&amp;action=edit\"><abbr title=\"Edit this template\" style=\";background:#efefef;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Concepts_in_pharmacology\" style=\"font-size:114%;margin:0 4em\">Concepts in <a href=\"/wiki/Pharmacology\" title=\"Pharmacology\">pharmacology</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pharmacokinetics\" title=\"Pharmacokinetics\">Pharmacokinetics</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/ADME\" title=\"ADME\">(L)ADME</a>: (<a href=\"/wiki/Liberation_(pharmacology)\" title=\"Liberation (pharmacology)\">Liberation</a>)</li>\n<li><a href=\"/wiki/Absorption_(pharmacokinetics)\" class=\"mw-redirect\" title=\"Absorption (pharmacokinetics)\">Absorption</a></li>\n<li><a href=\"/wiki/Distribution_(pharmacology)\" title=\"Distribution (pharmacology)\">Distribution</a></li>\n<li><a href=\"/wiki/Drug_metabolism\" title=\"Drug metabolism\">Metabolism</a></li>\n<li><a href=\"/wiki/Excretion\" title=\"Excretion\">Excretion</a> (<a href=\"/wiki/Clearance_(medicine)\" class=\"mw-redirect\" title=\"Clearance (medicine)\">Clearance</a>)</li></ul>\n<ul><li><a href=\"/wiki/Loading_dose\" title=\"Loading dose\">Loading dose</a></li>\n<li><a href=\"/wiki/Volume_of_distribution\" title=\"Volume of distribution\">Volume of distribution</a> (<a href=\"/wiki/Initial_volume_of_distribution\" title=\"Initial volume of distribution\">Initial</a>)</li>\n<li><a href=\"/wiki/Rate_of_infusion\" title=\"Rate of infusion\">Rate of infusion</a></li></ul>\n<ul><li><a href=\"/wiki/Compartment_(pharmacokinetics)\" title=\"Compartment (pharmacokinetics)\">Compartment</a></li>\n<li><a href=\"/wiki/Bioequivalence\" title=\"Bioequivalence\">Bioequivalence</a></li>\n<li><a href=\"/wiki/Bioavailability\" title=\"Bioavailability\">Bioavailability</a></li></ul>\n<ul><li><a href=\"/wiki/Onset_of_action\" title=\"Onset of action\">Onset of action</a></li>\n<li><a href=\"/wiki/Biological_half-life\" title=\"Biological half-life\">Biological half-life</a></li>\n<li><a href=\"/wiki/Plasma_protein_binding\" title=\"Plasma protein binding\">Plasma protein binding</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Pharmacodynamics\" title=\"Pharmacodynamics\">Pharmacodynamics</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Mechanism_of_action\" title=\"Mechanism of action\">Mechanism of action</a></li>\n<li><a href=\"/wiki/Mode_of_action\" title=\"Mode of action\">Mode of action</a></li>\n<li><a href=\"/wiki/Toxicity\" title=\"Toxicity\">Toxicity</a> (<a href=\"/wiki/Neurotoxicology\" class=\"mw-redirect\" title=\"Neurotoxicology\">Neurotoxicology</a>)</li>\n<li><a href=\"/wiki/Dose%E2%80%93response_relationship\" title=\"Dose\u2013response relationship\">Dose\u2013response relationship</a> (<a href=\"/wiki/Efficacy#Pharmacology\" title=\"Efficacy\">Efficacy</a>, <a href=\"/wiki/Potency_(pharmacology)\" title=\"Potency (pharmacology)\">Potency</a>)</li>\n<li><a href=\"/wiki/Therapeutic_index\" title=\"Therapeutic index\">Therapeutic index</a> (<a href=\"/wiki/Median_lethal_dose\" title=\"Median lethal dose\">Median lethal dose</a>, <a href=\"/wiki/Effective_dose_(pharmacology)\" title=\"Effective dose (pharmacology)\">Effective dose</a>)</li></ul>\n<ul><li><a href=\"/wiki/Antimicrobial_pharmacodynamics\" title=\"Antimicrobial pharmacodynamics\">Antimicrobial pharmacodynamics</a>: <a href=\"/wiki/Minimum_inhibitory_concentration\" title=\"Minimum inhibitory concentration\">Minimum inhibitory concentration</a> (<a href=\"/wiki/Bacteriostatic_agent\" title=\"Bacteriostatic agent\">Bacteriostatic</a>)</li>\n<li><a href=\"/wiki/Minimum_bactericidal_concentration\" title=\"Minimum bactericidal concentration\">Minimum bactericidal concentration</a> (<a href=\"/wiki/Bactericide\" title=\"Bactericide\">Bactericide</a>)</li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Agonism and<br /> antagonism</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Agonist\" title=\"Agonist\">Agonist</a>: <a href=\"/wiki/Inverse_agonist\" title=\"Inverse agonist\">Inverse agonist</a></li>\n<li><a href=\"/wiki/Irreversible_agonist\" title=\"Irreversible agonist\">Irreversible agonist</a></li>\n<li><a href=\"/wiki/Partial_agonist\" title=\"Partial agonist\">Partial agonist</a></li>\n<li><a href=\"/wiki/Superagonist\" title=\"Superagonist\">Superagonist</a></li>\n<li><a href=\"/wiki/Physiological_agonism_and_antagonism\" title=\"Physiological agonism and antagonism\">Physiological agonist</a></li></ul>\n<ul><li><a href=\"/wiki/Receptor_antagonist\" title=\"Receptor antagonist\">Antagonist</a>: <a href=\"/wiki/Competitive_antagonist\" class=\"mw-redirect\" title=\"Competitive antagonist\">Competitive antagonist</a></li>\n<li><a href=\"/wiki/Irreversible_antagonist\" title=\"Irreversible antagonist\">Irreversible antagonist</a></li>\n<li><a href=\"/wiki/Physiological_agonism_and_antagonism\" title=\"Physiological agonism and antagonism\">Physiological antagonist</a></li></ul>\n<ul><li>Other: <a href=\"/wiki/Molecular_binding\" title=\"Molecular binding\">Binding</a></li>\n<li><a href=\"/wiki/Dissociation_constant#Protein-ligand_binding\" title=\"Dissociation constant\">Affinity</a></li>\n<li><a href=\"/wiki/Binding_selectivity\" title=\"Binding selectivity\">Binding selectivity</a></li>\n<li><a href=\"/wiki/Functional_selectivity\" title=\"Functional selectivity\">Functional selectivity</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Other</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Drug_tolerance\" title=\"Drug tolerance\">Drug tolerance</a>: <a href=\"/wiki/Tachyphylaxis\" title=\"Tachyphylaxis\">Tachyphylaxis</a></li></ul>\n<ul><li><a href=\"/wiki/Drug_resistance\" title=\"Drug resistance\">Drug resistance</a>: <a href=\"/wiki/Antibiotic_resistance\" class=\"mw-redirect\" title=\"Antibiotic resistance\">Antibiotic resistance</a></li>\n<li><a href=\"/wiki/Multiple_drug_resistance\" title=\"Multiple drug resistance\">Multiple drug resistance</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Drug_discovery\" title=\"Drug discovery\">Drug discovery</a><br /> strategies</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Classical_pharmacology\" title=\"Classical pharmacology\">Classical pharmacology</a></li></ul>\n<ul><li><a href=\"/wiki/Reverse_pharmacology\" title=\"Reverse pharmacology\">Reverse pharmacology</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Related<br /> fields/subfields</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a class=\"mw-selflink selflink\">Pharmacogenetics</a></li>\n<li><a href=\"/wiki/Pharmacogenomics\" title=\"Pharmacogenomics\">Pharmacogenomics</a></li></ul>\n<ul><li><a href=\"/wiki/Neuropsychopharmacology\" title=\"Neuropsychopharmacology\">Neuropsychopharmacology</a> (<a href=\"/wiki/Neuropharmacology\" title=\"Neuropharmacology\">Neuropharmacology</a>, <a href=\"/wiki/Psychopharmacology\" title=\"Psychopharmacology\">Psychopharmacology</a>)</li></ul>\n</div></td></tr></tbody></table></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Omics\" style=\"padding:3px\"><table class=\"nowraplinks collapsible autocollapse navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th scope=\"col\" class=\"navbox-title\" colspan=\"2\"><div class=\"plainlinks hlist navbar mini\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Genomics\" title=\"Template:Genomics\"><abbr title=\"View this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Genomics\" title=\"Template talk:Genomics\"><abbr title=\"Discuss this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Genomics&amp;action=edit\"><abbr title=\"Edit this template\" style=\";;background:none transparent;border:none;-moz-box-shadow:none;-webkit-box-shadow:none;box-shadow:none; padding:0;\">e</abbr></a></li></ul></div><div id=\"Omics\" style=\"font-size:114%;margin:0 4em\"><a href=\"/wiki/Omics\" title=\"Omics\">Omics</a></div></th></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Genomics\" title=\"Genomics\">Genomics</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Cognitive_genomics\" title=\"Cognitive genomics\">Cognitive genomics</a></li>\n<li><a href=\"/wiki/Computational_genomics\" title=\"Computational genomics\">Computational genomics</a></li>\n<li><a href=\"/wiki/Comparative_genomics\" title=\"Comparative genomics\">Comparative genomics</a></li>\n<li><a href=\"/wiki/Functional_genomics\" title=\"Functional genomics\">Functional genomics</a></li>\n<li><a href=\"/wiki/Genome_project\" title=\"Genome project\">Genome project</a>\n<ul><li><a href=\"/wiki/Human_proteome_project\" title=\"Human proteome project\">Human Genome Project</a></li></ul></li>\n<li><a href=\"/wiki/Metagenomics\" title=\"Metagenomics\">Metagenomics</a></li>\n<li><a href=\"/wiki/Personal_genomics\" title=\"Personal genomics\">Personal genomics</a></li>\n<li><a href=\"/wiki/Social_genomics\" class=\"mw-redirect\" title=\"Social genomics\">Social genomics</a></li>\n<li><a href=\"/wiki/Structural_genomics\" title=\"Structural genomics\">Structural genomics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Bioinformatics\" title=\"Bioinformatics\">Bioinformatics</a></th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Biochip\" title=\"Biochip\">Biochip</a></li>\n<li><a href=\"/wiki/Cheminformatics\" title=\"Cheminformatics\">Cheminformatics</a></li>\n<li><a href=\"/wiki/Chemogenomics\" title=\"Chemogenomics\">Chemogenomics</a></li>\n<li><a href=\"/wiki/Connectomics\" title=\"Connectomics\">Connectomics</a></li>\n<li><a href=\"/wiki/Glycomics\" title=\"Glycomics\">Glycomics</a></li>\n<li><a href=\"/wiki/Immunomics\" title=\"Immunomics\">Immunomics</a></li>\n<li><a href=\"/wiki/Lipidomics\" title=\"Lipidomics\">Lipidomics</a></li>\n<li><a href=\"/wiki/Metabolomics\" title=\"Metabolomics\">Metabolomics</a></li>\n<li><a href=\"/wiki/Microbiome\" class=\"mw-redirect\" title=\"Microbiome\">Microbiomics</a></li>\n<li><a href=\"/wiki/Nutrigenomics\" title=\"Nutrigenomics\">Nutrigenomics</a></li>\n<li><a href=\"/wiki/Paleopolyploidy\" title=\"Paleopolyploidy\">Paleopolyploidy</a></li>\n<li><a class=\"mw-selflink selflink\">Pharmacogenetics</a></li>\n<li><a href=\"/wiki/Pharmacogenomics\" title=\"Pharmacogenomics\">Pharmacogenomics</a></li>\n<li><a href=\"/wiki/Systems_biology\" title=\"Systems biology\">Systems biology</a></li>\n<li><a href=\"/wiki/Toxicogenomics\" title=\"Toxicogenomics\">Toxicogenomics</a></li>\n<li><a href=\"/wiki/Transcriptomics\" class=\"mw-redirect\" title=\"Transcriptomics\">Transcriptomics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Structural_biology\" title=\"Structural biology\">Structural biology</a></th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/Proteomics\" title=\"Proteomics\">Proteomics</a>\n<ul><li><a href=\"/wiki/Human_Proteome_Project\" class=\"mw-redirect\" title=\"Human Proteome Project\">Human Proteome Project</a></li></ul></li>\n<li><a href=\"/wiki/Call-map_proteomics\" class=\"mw-redirect\" title=\"Call-map proteomics\">Call-map proteomics</a></li>\n<li><a href=\"/wiki/Structure-based_drug_design\" class=\"mw-redirect\" title=\"Structure-based drug design\">Structure-based drug design</a></li>\n<li><a href=\"/wiki/Expression_proteomics\" class=\"mw-redirect\" title=\"Expression proteomics\">Expression proteomics</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Research tools</th><td class=\"navbox-list navbox-even hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/2-D_electrophoresis\" class=\"mw-redirect\" title=\"2-D electrophoresis\">2-D electrophoresis</a></li>\n<li><a href=\"/wiki/Mass_spectrometer\" class=\"mw-redirect\" title=\"Mass spectrometer\">Mass spectrometer</a></li>\n<li><a href=\"/wiki/Electrospray_ionization\" title=\"Electrospray ionization\">Electrospray ionization</a></li>\n<li><a href=\"/wiki/Matrix-assisted_laser_desorption_ionization\" class=\"mw-redirect\" title=\"Matrix-assisted laser desorption ionization\">Matrix-assisted laser desorption ionization</a></li>\n<li><a href=\"/wiki/Matrix-assisted_laser_desorption_ionization-time_of_flight_mass_spectrometer\" class=\"mw-redirect\" title=\"Matrix-assisted laser desorption ionization-time of flight mass spectrometer\">Matrix-assisted laser desorption ionization-time of flight mass spectrometer</a></li>\n<li><a href=\"/wiki/Microfluidic-based_tools\" class=\"mw-redirect\" title=\"Microfluidic-based tools\">Microfluidic-based tools</a></li>\n<li><a href=\"/wiki/Isotope_affinity_tags\" class=\"mw-redirect\" title=\"Isotope affinity tags\">Isotope affinity tags</a></li></ul>\n</div></td></tr><tr><th scope=\"row\" class=\"navbox-group\" style=\"width:1%\">Organizations</th><td class=\"navbox-list navbox-odd hlist\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> (USA)</li>\n<li><a href=\"/wiki/DNA_Data_Bank_of_Japan\" title=\"DNA Data Bank of Japan\">DNA Data Bank of Japan</a> (JP)</li>\n<li><a href=\"/wiki/European_Molecular_Biology_Laboratory\" title=\"European Molecular Biology Laboratory\">European Molecular Biology Laboratory</a> (EU)</li>\n<li><a href=\"/wiki/Sanger_Centre\" class=\"mw-redirect\" title=\"Sanger Centre\">Sanger Centre</a> (EN)</li></ul>\n</div></td></tr></tbody></table></div>\n<div class=\"noprint metadata navbox\" role=\"navigation\" aria-label=\"Portals\" style=\"font-weight:bold;padding:0.4em 2em\"><ul style=\"margin:0.1em 0 0\"><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:Issoria_lathonia.jpg\" class=\"image\"><img alt=\"Issoria lathonia.jpg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/24px-Issoria_lathonia.jpg\" width=\"24\" height=\"17\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/36px-Issoria_lathonia.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/2/2d/Issoria_lathonia.jpg/48px-Issoria_lathonia.jpg 2x\" data-file-width=\"629\" data-file-height=\"445\" /></a></span><a href=\"/wiki/Portal:Biology\" title=\"Portal:Biology\">Biology portal</a></span></li><li style=\"display:inline\"><span style=\"display:inline-block;white-space:nowrap\"><span style=\"margin:0 0.5em\"><a href=\"/wiki/File:WHO_Rod.svg\" class=\"image\"><img alt=\"WHO Rod.svg\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/9px-WHO_Rod.svg.png\" width=\"9\" height=\"21\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/13px-WHO_Rod.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d6/WHO_Rod.svg/18px-WHO_Rod.svg.png 2x\" data-file-width=\"107\" data-file-height=\"250\" /></a></span><a href=\"/wiki/Portal:Medicine\" title=\"Portal:Medicine\">Medicine portal</a></span></li></ul></div>\n<div role=\"navigation\" class=\"navbox\" aria-labelledby=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q1358521&amp;#124;Edit_this_at_Wikidata\" style=\"padding:3px\"><table class=\"nowraplinks hlist navbox-inner\" style=\"border-spacing:0;background:transparent;color:inherit\"><tbody><tr><th id=\"Authority_control_frameless_&amp;#124;text-top_&amp;#124;10px_&amp;#124;alt=Edit_this_at_Wikidata_&amp;#124;link=https&amp;#58;//www.wikidata.org/wiki/Q1358521&amp;#124;Edit_this_at_Wikidata\" scope=\"row\" class=\"navbox-group\" style=\"width:1%\"><a href=\"/wiki/Help:Authority_control\" title=\"Help:Authority control\">Authority control</a> <a href=\"https://www.wikidata.org/wiki/Q1358521\" title=\"Edit this at Wikidata\"><img alt=\"Edit this at Wikidata\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/10px-Blue_pencil.svg.png\" width=\"10\" height=\"10\" style=\"vertical-align: text-top\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/15px-Blue_pencil.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/73/Blue_pencil.svg/20px-Blue_pencil.svg.png 2x\" data-file-width=\"600\" data-file-height=\"600\" /></a></th><td class=\"navbox-list navbox-odd\" style=\"text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px\"><div style=\"padding:0em 0.25em\">\n<ul><li><span class=\"nowrap\"><a href=\"/wiki/Integrated_Authority_File\" title=\"Integrated Authority File\">GND</a>: <span class=\"uid\"><a rel=\"nofollow\" class=\"external text\" href=\"https://d-nb.info/gnd/4271255-5\">4271255-5</a></span></span></li></ul>\n</div></td></tr></tbody></table></div>\n\n<!-- \nNewPP limit report\nParsed by mw1321\nCached time: 20180909184310\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.604 seconds\nReal time usage: 0.722 seconds\nPreprocessor visited node count: 2866/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 147085/2097152 bytes\nTemplate argument size: 17581/2097152 bytes\nHighest expansion depth: 19/40\nExpensive parser function count: 13/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 41272/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.327/10.000 seconds\nLua memory usage: 5.15 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  594.711      1 -total\n 35.86%  213.290      1 Template:Reflist\n 28.08%  167.020      5 Template:Ambox\n 27.84%  165.549     23 Template:Cite_journal\n 22.02%  130.943      1 Template:Multiple_issues\n 11.58%   68.890      5 Template:Delink\n 10.47%   62.265      1 Template:Clarify\n 10.41%   61.921      2 Template:Fix-span\n  9.99%   59.437      1 Template:Cleanup\n  8.13%   48.327      2 Template:Replace\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:1889064-0!canonical and timestamp 20180909184310 and revision id 853842368\n -->\n</div>"},"langlinks":[{"lang":"ar","url":"https://ar.wikipedia.org/wiki/%D8%B5%D9%8A%D8%AF%D9%84%D8%A9_%D8%AC%D9%8A%D9%86%D9%8A%D8%A9","langname":"Arabic","autonym":"\u0627\u0644\u0639\u0631\u0628\u064a\u0629","*":"\u0635\u064a\u062f\u0644\u0629 \u062c\u064a\u0646\u064a\u0629"},{"lang":"az","url":"https://az.wikipedia.org/wiki/Farmakogenetika","langname":"Azerbaijani","autonym":"az\u0259rbaycanca","*":"Farmakogenetika"},{"lang":"bs","url":"https://bs.wikipedia.org/wiki/Farmakogenetika","langname":"Bosnian","autonym":"bosanski","*":"Farmakogenetika"},{"lang":"cs","url":"https://cs.wikipedia.org/wiki/Farmakogenetika","langname":"Czech","autonym":"\u010de\u0161tina","*":"Farmakogenetika"},{"lang":"de","url":"https://de.wikipedia.org/wiki/Pharmakogenetik","langname":"German","autonym":"Deutsch","*":"Pharmakogenetik"},{"lang":"es","url":"https://es.wikipedia.org/wiki/Farmacogen%C3%A9tica","langname":"Spanish","autonym":"espa\u00f1ol","*":"Farmacogen\u00e9tica"},{"lang":"fr","url":"https://fr.wikipedia.org/wiki/Pharmacog%C3%A9n%C3%A9tique","langname":"French","autonym":"fran\u00e7ais","*":"Pharmacog\u00e9n\u00e9tique"},{"lang":"gl","url":"https://gl.wikipedia.org/wiki/Farmacoxen%C3%A9tica","langname":"Galician","autonym":"galego","*":"Farmacoxen\u00e9tica"},{"lang":"it","url":"https://it.wikipedia.org/wiki/Farmacogenetica","langname":"Italian","autonym":"italiano","*":"Farmacogenetica"},{"lang":"he","url":"https://he.wikipedia.org/wiki/%D7%A4%D7%A8%D7%9E%D7%A7%D7%95%D7%92%D7%A0%D7%98%D7%99%D7%A7%D7%94","langname":"Hebrew","autonym":"\u05e2\u05d1\u05e8\u05d9\u05ea","*":"\u05e4\u05e8\u05de\u05e7\u05d5\u05d2\u05e0\u05d8\u05d9\u05e7\u05d4"},{"lang":"kk","url":"https://kk.wikipedia.org/wiki/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0","langname":"Kazakh","autonym":"\u049b\u0430\u0437\u0430\u049b\u0448\u0430","*":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u043a\u0430"},{"lang":"nl","url":"https://nl.wikipedia.org/wiki/Farmacogenetica","langname":"Dutch","autonym":"Nederlands","*":"Farmacogenetica"},{"lang":"ja","url":"https://ja.wikipedia.org/wiki/%E9%81%BA%E4%BC%9D%E8%96%AC%E7%90%86%E5%AD%A6","langname":"Japanese","autonym":"\u65e5\u672c\u8a9e","*":"\u907a\u4f1d\u85ac\u7406\u5b66"},{"lang":"pl","url":"https://pl.wikipedia.org/wiki/Farmakogenetyka","langname":"Polish","autonym":"polski","*":"Farmakogenetyka"},{"lang":"pt","url":"https://pt.wikipedia.org/wiki/Farmacogen%C3%A9tica","langname":"Portuguese","autonym":"portugu\u00eas","*":"Farmacogen\u00e9tica"},{"lang":"ru","url":"https://ru.wikipedia.org/wiki/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0","langname":"Russian","autonym":"\u0440\u0443\u0441\u0441\u043a\u0438\u0439","*":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u043a\u0430"},{"lang":"sr","url":"https://sr.wikipedia.org/wiki/Farmakogenetika","langname":"Serbian","autonym":"\u0441\u0440\u043f\u0441\u043a\u0438 / srpski","*":"Farmakogenetika"},{"lang":"sh","url":"https://sh.wikipedia.org/wiki/Farmakogenetika","langname":"Serbo-Croatian","autonym":"srpskohrvatski / \u0441\u0440\u043f\u0441\u043a\u043e\u0445\u0440\u0432\u0430\u0442\u0441\u043a\u0438","*":"Farmakogenetika"},{"lang":"fi","url":"https://fi.wikipedia.org/wiki/Farmakogenetiikka","langname":"Finnish","autonym":"suomi","*":"Farmakogenetiikka"},{"lang":"th","url":"https://th.wikipedia.org/wiki/%E0%B9%80%E0%B8%A0%E0%B8%AA%E0%B8%B1%E0%B8%8A%E0%B8%9E%E0%B8%B1%E0%B8%99%E0%B8%98%E0%B8%B8%E0%B8%A8%E0%B8%B2%E0%B8%AA%E0%B8%95%E0%B8%A3%E0%B9%8C","langname":"Thai","autonym":"\u0e44\u0e17\u0e22","*":"\u0e40\u0e20\u0e2a\u0e31\u0e0a\u0e1e\u0e31\u0e19\u0e18\u0e38\u0e28\u0e32\u0e2a\u0e15\u0e23\u0e4c"},{"lang":"tr","url":"https://tr.wikipedia.org/wiki/Farmakogenetik","langname":"Turkish","autonym":"T\u00fcrk\u00e7e","*":"Farmakogenetik"},{"lang":"uk","url":"https://uk.wikipedia.org/wiki/%D0%A4%D0%B0%D1%80%D0%BC%D0%B0%D0%BA%D0%BE%D0%B3%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D0%BA%D0%B0","langname":"Ukrainian","autonym":"\u0443\u043a\u0440\u0430\u0457\u043d\u0441\u044c\u043a\u0430","*":"\u0424\u0430\u0440\u043c\u0430\u043a\u043e\u0433\u0435\u043d\u0435\u0442\u0438\u043a\u0430"}],"categories":[{"sortkey":"","hidden":"","*":"Articles_needing_cleanup_from_February_2016"},{"sortkey":"","hidden":"","*":"All_pages_needing_cleanup"},{"sortkey":"","hidden":"","*":"Cleanup_tagged_articles_with_a_reason_field_from_February_2016"},{"sortkey":"","hidden":"","*":"Wikipedia_pages_needing_cleanup_from_February_2016"},{"sortkey":"","hidden":"","*":"Articles_needing_additional_references_from_February_2016"},{"sortkey":"","hidden":"","*":"All_articles_needing_additional_references"},{"sortkey":"","hidden":"","*":"Articles_lacking_reliable_references_from_February_2016"},{"sortkey":"","hidden":"","*":"All_articles_lacking_reliable_references"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_in_need_of_updating_from_February_2016"},{"sortkey":"","hidden":"","*":"All_Wikipedia_articles_in_need_of_updating"},{"sortkey":"","hidden":"","*":"Articles_with_multiple_maintenance_issues"},{"sortkey":"","hidden":"","*":"All_articles_with_unsourced_statements"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_September_2013"},{"sortkey":"","hidden":"","*":"All_accuracy_disputes"},{"sortkey":"","hidden":"","*":"Articles_with_disputed_statements_from_February_2016"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_needing_clarification_from_February_2016"},{"sortkey":"","hidden":"","*":"All_articles_with_specifically_marked_weasel-worded_phrases"},{"sortkey":"","hidden":"","*":"Articles_with_specifically_marked_weasel-worded_phrases_from_February_2016"},{"sortkey":"","hidden":"","*":"Articles_with_unsourced_statements_from_February_2016"},{"sortkey":"","hidden":"","*":"Wikipedia_articles_with_GND_identifiers"},{"sortkey":"","*":"Pharmacology"},{"sortkey":"","*":"Pharmacy"}],"links":[{"ns":14,"exists":"","*":"Category:Articles needing cleanup from February 2016"},{"ns":14,"exists":"","*":"Category:Cleanup tagged articles with a reason field from February 2016"},{"ns":14,"*":"Category:Wikipedia categories needing cleanup from February 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia pages needing cleanup from February 2016"},{"ns":14,"exists":"","*":"Category:Articles needing additional references from February 2016"},{"ns":14,"exists":"","*":"Category:Articles lacking reliable references from February 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia articles in need of updating from February 2016"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from September 2013"},{"ns":14,"exists":"","*":"Category:Articles with disputed statements from February 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia articles needing clarification from February 2016"},{"ns":14,"exists":"","*":"Category:Articles with specifically marked weasel-worded phrases from February 2016"},{"ns":14,"exists":"","*":"Category:Articles with unsourced statements from February 2016"},{"ns":14,"exists":"","*":"Category:Wikipedia articles with GND identifiers"},{"ns":10,"exists":"","*":"Template:Pharmacology"},{"ns":10,"exists":"","*":"Template:Genomics"},{"ns":0,"exists":"","*":"2-D electrophoresis"},{"ns":0,"exists":"","*":"23andMe"},{"ns":0,"exists":"","*":"6-mercaptopurine"},{"ns":0,"exists":"","*":"ADME"},{"ns":0,"exists":"","*":"Absorption (pharmacokinetics)"},{"ns":0,"exists":"","*":"Adverse drug reactions"},{"ns":0,"exists":"","*":"Agonist"},{"ns":0,"exists":"","*":"Alleles"},{"ns":0,"exists":"","*":"Antibiotic resistance"},{"ns":0,"exists":"","*":"Antidepressant"},{"ns":0,"exists":"","*":"Antimicrobial pharmacodynamics"},{"ns":0,"exists":"","*":"Autoimmune diseases"},{"ns":0,"exists":"","*":"Azathioprine"},{"ns":0,"exists":"","*":"Bactericide"},{"ns":0,"exists":"","*":"Bacteriostatic agent"},{"ns":0,"exists":"","*":"Binding selectivity"},{"ns":0,"exists":"","*":"Bioavailability"},{"ns":0,"exists":"","*":"Biochip"},{"ns":0,"exists":"","*":"Bioequivalence"},{"ns":0,"exists":"","*":"Bioinformatics"},{"ns":0,"exists":"","*":"Biologic medical product"},{"ns":0,"exists":"","*":"Biological half-life"},{"ns":0,"exists":"","*":"Bone marrow suppression"},{"ns":0,"exists":"","*":"Butyrylcholinesterase"},{"ns":0,"exists":"","*":"CYP2C19"},{"ns":0,"exists":"","*":"CYP2D6"},{"ns":0,"exists":"","*":"Call-map proteomics"},{"ns":0,"exists":"","*":"Cancer"},{"ns":0,"exists":"","*":"Caucasian race"},{"ns":0,"exists":"","*":"Cheminformatics"},{"ns":0,"exists":"","*":"Chemogenomics"},{"ns":0,"exists":"","*":"Classical pharmacology"},{"ns":0,"exists":"","*":"Clearance (medicine)"},{"ns":0,"exists":"","*":"Codeine"},{"ns":0,"exists":"","*":"Cognitive genomics"},{"ns":0,"exists":"","*":"Comparative genomics"},{"ns":0,"exists":"","*":"Compartment (pharmacokinetics)"},{"ns":0,"exists":"","*":"Competitive antagonist"},{"ns":0,"exists":"","*":"Computational genomics"},{"ns":0,"exists":"","*":"Connectomics"},{"ns":0,"exists":"","*":"Coronary stent"},{"ns":0,"exists":"","*":"Cytidine deaminase"},{"ns":0,"exists":"","*":"Cytochrome P450 oxidase"},{"ns":0,"exists":"","*":"DNA Data Bank of Japan"},{"ns":0,"exists":"","*":"DeCODE genetics"},{"ns":0,"exists":"","*":"Diabetes mellitus"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dihydropyrimidine dehydrogenase"},{"ns":0,"exists":"","*":"Dissociation constant"},{"ns":0,"exists":"","*":"Distribution (pharmacology)"},{"ns":0,"exists":"","*":"Dose\u2013response relationship"},{"ns":0,"exists":"","*":"Drug discovery"},{"ns":0,"exists":"","*":"Drug metabolism"},{"ns":0,"exists":"","*":"Drug resistance"},{"ns":0,"exists":"","*":"Drug tolerance"},{"ns":0,"exists":"","*":"East Africa"},{"ns":0,"exists":"","*":"Effective dose (pharmacology)"},{"ns":0,"exists":"","*":"Efficacy"},{"ns":0,"exists":"","*":"Electrospray ionization"},{"ns":0,"exists":"","*":"Enzyme"},{"ns":0,"exists":"","*":"Epidermal growth factor receptor"},{"ns":0,"exists":"","*":"European Molecular Biology Laboratory"},{"ns":0,"exists":"","*":"Excretion"},{"ns":0,"exists":"","*":"Expression proteomics"},{"ns":0,"exists":"","*":"Food and Drug Administration"},{"ns":0,"exists":"","*":"Functional genomics"},{"ns":0,"exists":"","*":"Functional selectivity"},{"ns":0,"exists":"","*":"Genetics"},{"ns":0,"exists":"","*":"Genome-wide association study"},{"ns":0,"exists":"","*":"Genome project"},{"ns":0,"exists":"","*":"Genomics"},{"ns":0,"exists":"","*":"Genotype"},{"ns":0,"exists":"","*":"Genotyping"},{"ns":0,"exists":"","*":"Germline mutation"},{"ns":0,"exists":"","*":"Glycomics"},{"ns":0,"exists":"","*":"Heterozygous"},{"ns":0,"exists":"","*":"High-density lipoprotein"},{"ns":0,"exists":"","*":"Human Proteome Project"},{"ns":0,"exists":"","*":"Human proteome project"},{"ns":0,"exists":"","*":"Immunomics"},{"ns":0,"exists":"","*":"Initial volume of distribution"},{"ns":0,"exists":"","*":"Integrated Authority File"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"Inverse agonist"},{"ns":0,"exists":"","*":"Irreversible agonist"},{"ns":0,"exists":"","*":"Irreversible antagonist"},{"ns":0,"exists":"","*":"Isoniazid"},{"ns":0,"exists":"","*":"Isotope affinity tags"},{"ns":0,"exists":"","*":"KRAS"},{"ns":0,"exists":"","*":"Leukemia"},{"ns":0,"exists":"","*":"Liberation (pharmacology)"},{"ns":0,"exists":"","*":"Lipidomics"},{"ns":0,"exists":"","*":"Loading dose"},{"ns":0,"exists":"","*":"Mass spectrometer"},{"ns":0,"exists":"","*":"Matrix-assisted laser desorption ionization"},{"ns":0,"exists":"","*":"Matrix-assisted laser desorption ionization-time of flight mass spectrometer"},{"ns":0,"exists":"","*":"Mean lifetime"},{"ns":0,"exists":"","*":"Mechanism of action"},{"ns":0,"exists":"","*":"Median lethal dose"},{"ns":0,"exists":"","*":"Metabolic pathway"},{"ns":0,"exists":"","*":"Metabolite"},{"ns":0,"exists":"","*":"Metabolize"},{"ns":0,"exists":"","*":"Metabolomics"},{"ns":0,"exists":"","*":"Metagenomics"},{"ns":0,"exists":"","*":"Microbiome"},{"ns":0,"exists":"","*":"Microfluidic-based tools"},{"ns":0,"exists":"","*":"Minimum bactericidal concentration"},{"ns":0,"exists":"","*":"Minimum inhibitory concentration"},{"ns":0,"exists":"","*":"Mode of action"},{"ns":0,"exists":"","*":"Molecular binding"},{"ns":0,"exists":"","*":"Multiple drug resistance"},{"ns":0,"exists":"","*":"Mutation"},{"ns":0,"exists":"","*":"N-acetyltransferase"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Navigenics"},{"ns":0,"exists":"","*":"Neuropharmacology"},{"ns":0,"exists":"","*":"Neuropsychopharmacology"},{"ns":0,"exists":"","*":"Neurotoxicology"},{"ns":0,"exists":"","*":"Nutrigenomics"},{"ns":0,"exists":"","*":"Omics"},{"ns":0,"exists":"","*":"Onset of action"},{"ns":0,"exists":"","*":"Paleopolyploidy"},{"ns":0,"exists":"","*":"Partial agonist"},{"ns":0,"exists":"","*":"Pegylated interferon-alpha-2a"},{"ns":0,"exists":"","*":"Pegylated interferon-alpha-2b"},{"ns":0,"exists":"","*":"Personal genomics"},{"ns":0,"exists":"","*":"Personalized medicine"},{"ns":0,"exists":"","*":"Pharmacodynamics"},{"ns":0,"exists":"","*":"Pharmacogenomics"},{"ns":0,"exists":"","*":"Pharmacokinetics"},{"ns":0,"exists":"","*":"Pharmacology"},{"ns":0,"exists":"","*":"Pharmacovigilance"},{"ns":0,"exists":"","*":"Physiological agonism and antagonism"},{"ns":0,"exists":"","*":"Plasma protein binding"},{"ns":0,"exists":"","*":"Plavix"},{"ns":0,"exists":"","*":"Polymorphism (biology)"},{"ns":0,"exists":"","*":"Potency (pharmacology)"},{"ns":0,"exists":"","*":"Procainamide"},{"ns":0,"exists":"","*":"Proteomics"},{"ns":0,"exists":"","*":"Psychopharmacology"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Rate of infusion"},{"ns":0,"exists":"","*":"Receptor antagonist"},{"ns":0,"exists":"","*":"Reverse pharmacology"},{"ns":0,"exists":"","*":"Ribavirin"},{"ns":0,"exists":"","*":"Sanger Centre"},{"ns":0,"exists":"","*":"Single-nucleotide polymorphism"},{"ns":0,"exists":"","*":"Social genomics"},{"ns":0,"exists":"","*":"Structural biology"},{"ns":0,"exists":"","*":"Structural genomics"},{"ns":0,"exists":"","*":"Structure-based drug design"},{"ns":0,"exists":"","*":"Superagonist"},{"ns":0,"exists":"","*":"Suxamethonium chloride"},{"ns":0,"exists":"","*":"Systems biology"},{"ns":0,"exists":"","*":"TPMT"},{"ns":0,"exists":"","*":"Tachyphylaxis"},{"ns":0,"exists":"","*":"Therapeutic index"},{"ns":0,"exists":"","*":"Thiopurine"},{"ns":0,"exists":"","*":"Thiopurine methyltransferase"},{"ns":0,"exists":"","*":"Toxicity"},{"ns":0,"exists":"","*":"Toxicogenomics"},{"ns":0,"exists":"","*":"Transcriptomics"},{"ns":0,"exists":"","*":"UGT1A1"},{"ns":0,"exists":"","*":"Volume of distribution"},{"ns":0,"exists":"","*":"Wild-type"},{"ns":0,"exists":"","*":"Xenobiotic"},{"ns":0,"*":"Blood concentration"},{"ns":1,"exists":"","*":"Talk:Pharmacogenetics"},{"ns":4,"exists":"","*":"Wikipedia:Accuracy dispute"},{"ns":4,"exists":"","*":"Wikipedia:Avoid weasel words"},{"ns":4,"exists":"","*":"Wikipedia:Citation needed"},{"ns":4,"exists":"","*":"Wikipedia:Citing sources"},{"ns":4,"exists":"","*":"Wikipedia:Cleanup"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources"},{"ns":4,"exists":"","*":"Wikipedia:Identifying reliable sources (medicine)"},{"ns":4,"exists":"","*":"Wikipedia:Manual of Style"},{"ns":4,"exists":"","*":"Wikipedia:Please clarify"},{"ns":4,"exists":"","*":"Wikipedia:Verifiability"},{"ns":11,"exists":"","*":"Template talk:Genomics"},{"ns":11,"exists":"","*":"Template talk:Pharmacology"},{"ns":12,"exists":"","*":"Help:Authority control"},{"ns":12,"exists":"","*":"Help:Introduction to referencing with Wiki Markup/1"},{"ns":12,"exists":"","*":"Help:Maintenance template removal"},{"ns":100,"exists":"","*":"Portal:Biology"},{"ns":100,"exists":"","*":"Portal:Medicine"}],"templates":[{"ns":10,"exists":"","*":"Template:Multiple issues"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Cleanup"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:SUBJECTSPACE formatted"},{"ns":10,"exists":"","*":"Template:Category handler"},{"ns":10,"exists":"","*":"Template:DMC"},{"ns":10,"exists":"","*":"Template:Dated maintenance category"},{"ns":10,"exists":"","*":"Template:FULLROOTPAGENAME"},{"ns":10,"exists":"","*":"Template:Ns has subpages"},{"ns":10,"exists":"","*":"Template:DMCA"},{"ns":10,"exists":"","*":"Template:Refimprove"},{"ns":10,"exists":"","*":"Template:More citations needed"},{"ns":10,"exists":"","*":"Template:Unreliable sources"},{"ns":10,"exists":"","*":"Template:If affirmed"},{"ns":10,"exists":"","*":"Template:Update"},{"ns":10,"exists":"","*":"Template:Unreliable medical source"},{"ns":10,"exists":"","*":"Template:Fix"},{"ns":10,"exists":"","*":"Template:Fix/category"},{"ns":10,"exists":"","*":"Template:Delink"},{"ns":10,"exists":"","*":"Template:Citation needed"},{"ns":10,"exists":"","*":"Template:Dubious"},{"ns":10,"exists":"","*":"Template:Clarify"},{"ns":10,"exists":"","*":"Template:Fix-span"},{"ns":10,"exists":"","*":"Template:Replace"},{"ns":10,"exists":"","*":"Template:Weasel inline"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Refbegin"},{"ns":10,"exists":"","*":"Template:Refbegin/styles.css"},{"ns":10,"exists":"","*":"Template:Column-count"},{"ns":10,"exists":"","*":"Template:Refend"},{"ns":10,"exists":"","*":"Template:Pharmacology"},{"ns":10,"exists":"","*":"Template:Navbox"},{"ns":10,"exists":"","*":"Template:Genomics"},{"ns":10,"exists":"","*":"Template:Portal bar"},{"ns":10,"exists":"","*":"Template:Authority control"},{"ns":10,"exists":"","*":"Template:EditAtWikidata"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Ns has subpages"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Delink"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Navbox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:Portal bar"},{"ns":828,"exists":"","*":"Module:Portal"},{"ns":828,"exists":"","*":"Module:Portal/images/b"},{"ns":828,"exists":"","*":"Module:Portal/images/m"},{"ns":828,"exists":"","*":"Module:Authority control"},{"ns":828,"exists":"","*":"Module:ResolveEntityId"},{"ns":828,"exists":"","*":"Module:EditAtWikidata"}],"images":["Lock-green.svg","Ambox_important.svg","Edit-clear.svg","Question_book-new.svg","Text_document_with_red_question_mark.svg","Ambox_current_red.svg","Issoria_lathonia.jpg","WHO_Rod.svg","Blue_pencil.svg"],"externallinks":["//doi.org/10.2165/00003088-200746040-00001","//www.ncbi.nlm.nih.gov/pubmed/17375979","https://pharmacy.unc.edu/research/centers/cpit/","//doi.org/10.1038/35015728","//www.ncbi.nlm.nih.gov/pubmed/10866212","//doi.org/10.1517/17425255.2015.1108964","//www.ncbi.nlm.nih.gov/pubmed/26548636","//doi.org/10.1001/jama.279.15.1200","//www.ncbi.nlm.nih.gov/pubmed/9555760","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1569528","//doi.org/10.1098/rstb.2005.1685","//www.ncbi.nlm.nih.gov/pubmed/16096104","//doi.org/10.2174/138161210790112728","//www.ncbi.nlm.nih.gov/pubmed/20205659","http://www.dailyfinance.com/2011/02/27/top-selling-drugs-are-about-to-lose-patent-protection-ready/","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3641569","//doi.org/10.1001/jama.2009.1232","//www.ncbi.nlm.nih.gov/pubmed/19706858","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3200506","//doi.org/10.1016/j.atherosclerosis.2011.06.005","//www.ncbi.nlm.nih.gov/pubmed/21722898","//doi.org/10.1007/s00280-010-1282-4","//www.ncbi.nlm.nih.gov/pubmed/20204365","http://www.psychiatrictimes.com/neuropsychiatry/content/article/10168/1550787","//doi.org/10.1124/pr.58.3.6","//www.ncbi.nlm.nih.gov/pubmed/16968950","https://web.archive.org/web/20090202101452/http://learn.genetics.utah.edu/content/health/pharma/intro/","http://learn.genetics.utah.edu/content/health/pharma/intro/","https://web.archive.org/web/20050409170510/http://discoverysedge.mayo.edu/pharmacogenomics/","http://discoverysedge.mayo.edu/pharmacogenomics/","//doi.org/10.1038/nature08309","//www.ncbi.nlm.nih.gov/pubmed/19684573","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3172006","//doi.org/10.1038/nature08463","//www.ncbi.nlm.nih.gov/pubmed/19759533","//doi.org/10.1592/phco.28.8.992","//www.ncbi.nlm.nih.gov/pubmed/18657016","//doi.org/10.2174/187569211796957566","http://www.huffingtonpost.com/dr-soram-khalsa/pharmacogenetics-what-it-is-_b_7683164.html","//www.ncbi.nlm.nih.gov/pmc/articles/PMC5493454","//doi.org/10.7759/cureus.1289","//www.ncbi.nlm.nih.gov/pubmed/28680777","//doi.org/10.2174/138945006779025428","//www.ncbi.nlm.nih.gov/pubmed/17168846","//doi.org/10.1038/nrg1431","//www.ncbi.nlm.nih.gov/pubmed/15372090","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1734105","//doi.org/10.1136/jme.2004.007229","//www.ncbi.nlm.nih.gov/pubmed/15738433","https://www.wikidata.org/wiki/Q1358521","https://rxight.com","//doi.org/10.1038/425760a","//www.ncbi.nlm.nih.gov/pubmed/14574377","//doi.org/10.1056/NEJMra020526","//www.ncbi.nlm.nih.gov/pubmed/12571262","//doi.org/10.1001/jama.286.18.2270","//www.ncbi.nlm.nih.gov/pubmed/11710893","//doi.org/10.1056/NEJMra020021","//www.ncbi.nlm.nih.gov/pubmed/12571261","http://www.ornl.gov/sci/techresources/Human_Genome/medicine/pharma.shtml","https://www.springer.com/humana+press/pharmacology+and+toxicology/book/978-1-58829-887-4","https://d-nb.info/gnd/4271255-5"],"sections":[{"toclevel":1,"level":"2","line":"Predicting drug-drug interactions","number":"1","index":"1","fromtitle":"Pharmacogenetics","byteoffset":2685,"anchor":"Predicting_drug-drug_interactions"},{"toclevel":1,"level":"2","line":"History","number":"2","index":"2","fromtitle":"Pharmacogenetics","byteoffset":12643,"anchor":"History"},{"toclevel":1,"level":"2","line":"Thiopurines and TPMT (thiopurine methyl transferase)","number":"3","index":"3","fromtitle":"Pharmacogenetics","byteoffset":14723,"anchor":"Thiopurines_and_TPMT_(thiopurine_methyl_transferase)"},{"toclevel":1,"level":"2","line":"Hepatitis C","number":"4","index":"4","fromtitle":"Pharmacogenetics","byteoffset":17668,"anchor":"Hepatitis_C"},{"toclevel":1,"level":"2","line":"Integrating into the health care system","number":"5","index":"5","fromtitle":"Pharmacogenetics","byteoffset":19442,"anchor":"Integrating_into_the_health_care_system"},{"toclevel":2,"level":"3","line":"Technological advances","number":"5.1","index":"6","fromtitle":"Pharmacogenetics","byteoffset":22752,"anchor":"Technological_advances"},{"toclevel":1,"level":"2","line":"Ethics","number":"6","index":"7","fromtitle":"Pharmacogenetics","byteoffset":24050,"anchor":"Ethics"},{"toclevel":1,"level":"2","line":"See also","number":"7","index":"8","fromtitle":"Pharmacogenetics","byteoffset":26719,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"8","index":"9","fromtitle":"Pharmacogenetics","byteoffset":26852,"anchor":"References"},{"toclevel":1,"level":"2","line":"Further reading","number":"9","index":"10","fromtitle":"Pharmacogenetics","byteoffset":26885,"anchor":"Further_reading"},{"toclevel":1,"level":"2","line":"External links","number":"10","index":"11","fromtitle":"Pharmacogenetics","byteoffset":28046,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Pharmacogenetics","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q1358521"}]}}